Citrus Sinensis ID: 000578

Local Sequence Feature Prediction

Prediction and (Method)	Result

Residue Number Marker

Protein Sequence

Secondary Structure (PSIPRED)

Secondary Structure Prediction (SSPRO)

Coil and Loop (DISEMBL)

Flexible Loop (DISEMBL)

Low Complexity Region (SEG)

Disordered region (IsUnstruct)

Disordered Region (DISOPRED)

Disordered Region (DISEMBL)

Disordered Region (DISPRO)

Transmembrane Helix (TMHMM)

Transmembrane Helix (HMMTOP)

Transmembrane Helix (MEMSAT)

TM Helix, Signal Peptide (MEMSAT_SVM)

TM Helix, Signal Peptide (Phobius)

Signal Peptide (SignalP HMM Mode)

Signal Peptide (SignalP NN Mode)

Coiled Coils (COILS)

Positional Conservation

--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------870-------880-------890-------900-------910-------920-------930-------940-------950-------960-------970-------980-------990------1000------1010------1020------1030------1040------1050------1060------1070------1080------1090------1100------1110------1120------1130------1140------1150------1160------1170------1180------1190------1200------1210------1220------1230------1240------1250------1260------1270------1280------1290------1300------1310------1320------1330------1340------1350------1360------1370------1380------1390------1400------1410--

MEEVVDWHSDHDIVHAVWTLVHMCCSDDASSIRAWVSDFISRVGIGDPHCVVFHLPRDSIYMHACRPINHGSGSATEFNFHLDAGISEELLIAVLKILKKYLMDDSVQIVDMTSQTLRGILSTEKGQRAVMSFDSYERSLLEVHSKGVNVELVETFLLDLERKFKANGISPEKSTVWETDGKTFETWICPLTYSLIGCCNDVVLRLCQDIVLLKSEVAELLLPSVVVNLAGSKNVDVDLQKLISSQVQKYIFTESNKLIKSIQVFLNALNELRLCHVMERSSSVPPKRESSKYVKHSGSSAKPRSTSAKARDVVATSNATMTTSWDKVYWLSVDYLRVAKSAVICGSYFTSVMYVEHWCEEHYKSLTLGSPDFSHLETLPRHIEILVSAVTQINEPDSLYGIIQSHKLSSQIVTLEHEGNWSKALEYYELQVRSDVMLQMDGNSGALSPHGLPSVHLSPSTSENEMMQRKPYKGLMRSLQQVGCMHVLDMYCKGLTSWKGQFQHDPEFTKLQYEAAWRTGNWDFSLPYLGANFPSGQNIKSGHFHENLHSCLTALREGDSEEFYRKLKHSKQELVLSVACASEESTEYIYSAIVKLQILCHLGVAWDIRWKSSGESINIYPEKQKIVSEPVIPTVGQLSWLNTEWSSILKRTQLHMNLLEPFMAFRRVLLQILSCKDFTMQHLLESASTLRKGFRLSQAAAALHELKFLYTGPGDQCSTVYWLGRLEEAKLLRAQGQHEMAINLAKYISENYESNEEAPDVYRLVGKWLAESRSSNSRIILENYLKPAVSFSEDQRTTDKKSIERQCQTHFHLAHYADALFKSYEERLASNEWQAAMRLRKHKTIELEALIKRLKSSTKGEKTDYSIKIQELQKQLAMDREEAQKLLDDRDNFLGLALEGYKRCLVIGDKYDVRVVFRLVSLWFSLSSRQNVIKNMVDTIDELLALANGDRIKDKQRSRNSFVVDMDKKLAAENLLEELSSYHGAIIRQMKQMVDVYIKLAELETRREDTNKRIQLPREIRCLRQLELVPVVTATVPIDCTCQYNEGSFPYFKGLAESVMVMNGINAPKVVECFGSDGHKYRQLAKSGNDDLRQDAVMEQFFGLVNTFLRNHRDTWKRRLGVRTYKVVPFTPSAGILEWVDGTVPLGDYLIGSTRNGGAHGRYGIGDWSFLKCREHMSNVKDKRIAFQEVCENFRPVLHYFFLERFLQPAYWFEKRLAYTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFEQGLMLKTPERVPFRLTRDIIDGMGVTGVEGVFRRCCEKTLSVMRTNKEALLTIVEVFIHDPLYKWALSPLKALQRQKEMDDDLETGLEGPEDEYEGNKDAERALIRVKQKLDGYEGGEMRSVHGQVQQLIQDAIDPERFCLMFPGWGAWL

ccccccccccHHHHHHHHHHHHHHHccccccHHHHHHHHHHHHcccccccccccccccccccccccccccccccccHHccccccccHHHHHHHHHHHHHHHHHcccHHHHHHHHHHHHHHHccHHHHHHHHHcHHHHHHHHHHHHcccccHHHHHHHHHHHHHHcccccccccccccccccccHHHHHHHHHHHHHHccccHHHHHHHHHHHccHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHHHHHcccHHHHHHHHHHHHHHHHHHHHHHHHcccccccccHHHHHHHHccccccccccccccHHHHHHccccccccccccccccccHHHHHHHHHHHcHHHHHHHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHcccccccccccccccHHHHHHHHHHcccHHHHHHHHHHHHHccHHHHccccccccccccccccccccccHHHHHHHHccHHHHHHHHHHcccHHHHHHHHHccccccccccccHHHHHHHHHHHHHHccccccccccccccccccccccccHHHHHHHHHHHHHcccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccHHHHccccccccHHHHHHHHHHHHHHHHHHHHcccHHHHHHHHHHHHHHHHccHHHHHHHHHHHHHHHHHcccHHHHHHHHHHHHHHccccccccccHHHHcHHHHHHHHHHcccHHHHHHHHHHHHHHccccccHHHHHHHHHHHHHHHccccHHHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcHHHHHHHHHHHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHHHHHcHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHHccHHHHHHHHHHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccHHHHHHHHcccccccccccccccccccccccccEEEEEccEEEEcccccccEEEEEEEcccccEEEEcccccccccHHHHHHHHHHHHHHHHcccccccccccccccccEEEccccccEEEccccccHHHHHHHHHHHcccccccccccccHHHHHHHHcccHHHHHHHHHHHHHHccHHHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccEEEEEcHHHHHccccccccccccccccHHHHHHccccccccHHHHHHHHHHHHHHccHHHHHHHHHHHHccccccccccHHHHHHHHccccccccccccccccccccHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHHccHHHHHHHcccccccc

ccHHHcccccHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHcccccccEEEEEEccccEEEcccHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHHHHccccccccHHHHHHHHHHHccccccHHHHHHHccHHHHHHcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHccHHHHHHHHHHHHHccHHHHHHHHHHHHHHHHccccccHHHHHHHHHHHHccccccccccHHHHHHHHHHHHHHHHHHHHHHHccccHHHHHHHHccccccccccccHHHHHHHHHHcccccccEEHHHHHHHcccHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccHHHcHHHHHHHHHHHHHccccccccccccHHHHHHHHHHHHHcccHHHHHHHHHHHHHccccccHHHccccccccccccccccccccccccccHHHHHHHHHHHHHcccHHHHHHHHHccHHccccccccHHHHHHHHHHHHHHccHHHHHHHHHHccccccccccccHcHHHHHHHHHHHHccHHHHHHHHHHHHHHHHHHHHHHcHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccHHcccccccccccccccccHHHHHHHHHHHHHHHHHcccccccHHHHHHHHHHHHHHccccHHHHHHHHHHHHHHHHcccHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHHHHcccHHHHHHHHHHHHHccccccHHHHHHHHHHHHHHHHccccHHHHHHHHHHHHHHHHHHcccccHHHccHHHHHHHHHHHHHHHHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHHHHHccccccccHHHHHHHHHHHHHHccHHHHHHHHHcHHHHHHHHHHHHHHHccccccccHHHHHHHHHHHHHHHHccHHHHHHHHHHHHHHHHHcHHHHHHHHcccccccccHHHHHHHHHHHHHHcHHHHHHHHHHHHHHHHHHHHHHccccccccEEEEccccccccccEcccEEEcccEcccccccccccccccEEEcccccEEEHcccccccEEEEEEccccEEEEEEcccccHHHHHHHHHHHHHHHHHHHHccHHHHccEEEEEEEEEEcccccccEEEEccccccHHHHHHHHHHHccccccccccHHHHHHHHHHcccHHHHHHHHHHHHHHcccHHHHHHHHHcccHHHHHHHHHHHHHHHHHHHHHHHHEccccccccEEEEEcccccEEEEEccHHHccccccccccEcccEccHHHHHHccccccccHHHHHHHHHHHHHHHcHHHHHHHHHHHHcccHHHHcccHHHHHHHccccccccccccccccccccccHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHccHHHHHHHcccccccc

meevvdwhsdhdIVHAVWTLVHMCCSDDASSIRAWVSDFISrvgigdphcvvfhlprdsiymhacrpinhgsgsatefnfhldaGISEELLIAVLKILKKYLMDDSVQIVDMTSQTLRGILSTEKGQRAVMSFDSYERSLLEVHSKGVNVELVETFLLDLERKFkangispekstvwetdgktfetwicpltysligcCNDVVLRLCQDIVLLKSEVAELLLPSVVVNLAGSKNVDVDLQKLISSQVQKYIFTESNKLIKSIQVFLNALNELRLCHVmersssvppkresskyvkhsgssakprstsakarDVVATSNATMTTSWDKVYWLSVDYLRVAKSAVICGSYFTSVMYVEHWCEEHYksltlgspdfshletlPRHIEILVSAVtqinepdslyGIIQSHKLSSQIVTLEHEGNWSKALEYYELQVRSDVMlqmdgnsgalsphglpsvhlspstsenemmqrkpykgLMRSLQQVGCMHVLDMYCKGltswkgqfqhdpeftKLQYEAAWRtgnwdfslpylganfpsgqniksghfhENLHSCLTALREGDSEEFYRKLKHSKQELVLSVACASEESTEYIYSAIVKLQILCHLGvawdirwkssgesiniypekqkivsepviptvgqlswlNTEWSSILKRTQLHMNLLEPFMAFRRVLLQILSCKDFTMQHLLESASTLRKGFRLSQAAAALHELKflytgpgdqcstvyWLGRLEEAKLLRAQGQHEMAINLAKYISenyesneeapDVYRLVGKWLAesrssnsriilenylkpavsfsedqrttdkkSIERQCQTHFHLAHYADALFKSYEERLASNEWQAAMRLRKHKTIELEALIKRLKsstkgektdYSIKIQELQKQLAMDREEAQKLLDDRDNFLGLALEGYKRCLVIGDKYDVRVVFRLVSLWFSLSSRQNVIKNMVDTIDELLALAngdrikdkqrsrnsfvvDMDKKLAAENLLEELSSYHGAIIRQMKQMVDVYIKLAELETRREDTNKRIQLPREIRCLrqlelvpvvtatvpidctcqynegsfpyfKGLAESVMVMnginapkvvecfgsdghkyRQLAKSGNDDLRQDAVMEQFFGLVNTFLRNHRDtwkrrlgvrtykvvpftpsagilewvdgtvplgdyligstrnggahgrygigdwsfLKCREHMSNVKDKRIAFQEVCENFRPVLHYFFLERFLQPAYWFEKRLAYTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAfeqglmlktpervpfrltrdiidgmgvtgvEGVFRRCCEKTLSVMRTNKEALLTIVEVFIhdplykwalspLKALQRQKEMDddletglegpedeyegnkDAERALIRVKQKldgyeggemrsvHGQVQQLIQDAidperfclmfpgwgawl

MEEVVDWHSDHDIVHAVWTLVHMCCSDDASSIRAWVSDFISRVGIGDPHCVVFHLPRDSIYMHACRPINHGSGSATEFNFHLDAGISEELLIAVLKILKKYLMDDSVQIVDMTSQTLRGILSTEKGQRAVMSFDSYERSLLEVHSKGVNVELVETFLLDLERkfkangispekstvwetdgKTFETWICPLTYSLIGCCNDVVLRLCQDIVLLKSEVAELLLPSVVVNLAGSKNVDVDLQKLISSQVQKYIFTESNKLIKSIQVFLNALNELRLCHVMersssvppkresskyvkhsgssakprstsakardvvatsnatmttswdkVYWLSVDYLRVAKSAVICGSYFTSVMYVEHWCEEHYKSLTLGSPDFSHLETLPRHIEILVSAVTQINEPDSLYGIIQSHKLSSQIVTLEHEGNWSKALEYYELQVRSDVMLQMDGNSGALSPHGLPSVHLSPSTSENEMMQRKPYKGLMRSLQQVGCMHVLDMYCKGLTSWKGQFQHDPEFTKLQYEAAWRTGNWDFSLPYLGANFPSGQNIKSGHFHENLHSCLTALREGDSEEFYRKLKHSKQELVLSVACASEESTEYIYSAIVKLQILCHLGVAWDIRWKSSGESINIYpekqkivsepviPTVGQLSWLNTEWSSILKRTQLHMNLLEPFMAFRRVLLQILSCKDFTMQHLLESASTLRKGFRLSQAAAALHELKFLYTGPGDQCSTVYWLGRLEEAKLLRAQGQHEMAINLAKYISENYESNEEAPDVYRLVGKWLAEsrssnsriilenylkpavsfsedqRTTDKKSIERQCQTHFHLAHYADALFKSYEERLASNEWQAAMRLRKHKTIELEALIKrlksstkgektdysiKIQELQKQLAMDREEAQKLLDDRDNFLGLALEGYKRCLVIGDKYDVRVVFRLVSLWFSLSSRQNVIKNMVDTIDELLALangdrikdkqrsrnsfvvdMDKKLAAENLLEELSSYHGAIIRQMKQMVDVYIKLAeletrredtnkriqlpreirclrqlelVPVVTATVPIDCTCQYNEGSFPYFKGLAESVMVMNGINAPKVVECFGSDGHKYRQLAKSGNDDLRQDAVMEQFFGLVNTFlrnhrdtwkrrlgvrtykvvpftpsagilewVDGTVPLGDYLIGstrnggahgrYGIGDWSFLKCREHMSNVKDKRIAFQEVCENFRPVLHYFFLERFLQPAYWFEKRLAYTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFeqglmlktpervpfRLTRDIIDgmgvtgvegVFRRCCEKTLSVMRTNKEALLTIVEVFIHDPLYKWALSPLKALQRQKEMDDDLETglegpedeyegnkdaeRALIRVKQKLDGYEGGEMRSVHGQVQQLIQDAIDPERFCLMFPGWGAWL

MEEVVDWHSDHDIVHAVWTLVHMCCSDDASSIRAWVSDFISRVGIGDPHCVVFHLPRDSIYMHACRPINHGSGSATEFNFHLDAGISEELLIAVLKILKKYLMDDSVQIVDMTSQTLRGILSTEKGQRAVMSFDSYERSLLEVHSKGVNVELVETFLLDLERKFKANGISPEKSTVWETDGKTFETWICPLTYSLIGCCNDVVLRLCQDIVLLKSEVAELLLPSVVVNLAGSKNVDVDLQKLISSQVQKYIFTESNKLIKSIQVFLNALNELRLCHVMERSSSVPPKRESSKYVKHSGSSAKPRSTSAKARDVVATSNATMTTSWDKVYWLSVDYLRVAKSAVICGSYFTSVMYVEHWCEEHYKSLTLGSPDFSHLETLPRHIEILVSAVTQINEPDSLYGIIQSHKLSSQIVTLEHEGNWSKALEYYELQVRSDVMLQMDGNSGALSPHGLPSVHLSPSTSENEMMQRKPYKGLMRSLQQVGCMHVLDMYCKGLTSWKGQFQHDPEFTKLQYEAAWRTGNWDFSLPYLGANFPSGQNIKSGHFHENLHSCLTALREGDSEEFYRKLKHSKQELVLSVACASEESTEYIYSAIVKLQILCHLGVAWDIRWKSSGESINIYPEKQKIVSEPVIPTVGQLSWLNTEWSSILKRTQLHMNLLEPFMAFRRVLLQILSCKDFTMQHLLESASTLRKGFRLSQAAAALHELKFLYTGPGDQCSTVYWLGRLEEAKLLRAQGQHEMAINLAKYISENYESNEEAPDVYRLVGKWLAESRSSNSRIILENYLKPAVSFSEDQRTTDKKSIERQCQTHFHLAHYADALFKSYEERLASNEWQAAMRLRKHKTIELEALIKRLKSSTKGEKTDYSIKIQELQKQLAMDREEAQKLLDDRDNFLGLALEGYKRCLVIGDKYDVRVVFRLVSLWFSLSSRQNVIKNMVDTIDELLALANGDRIKDKQRSRNSFVVDMDKKlaaenlleelSSYHGAIIRQMKQMVDVYIKLAELETRREDTNKRIQLPREIRCLRQLELVPVVTATVPIDCTCQYNEGSFPYFKGLAESVMVMNGINAPKVVECFGSDGHKYRQLAKSGNDDLRQDAVMEQFFGLVNTFLRNHRDTWKRRLGVRTYKVVPFTPSAGILEWVDGTVPLGDYLIGSTRNGGAHGRYGIGDWSFLKCREHMSNVKDKRIAFQEVCENFRPVLHYFFLERFLQPAYWFEKRLAYTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFEQGLMLKTPERVPFRLTRDIIDGMGVTGVEGVFRRCCEKTLSVMRTNKEALLTIVEVFIHDPLYKWALSPLKALQRQKEMDDDLETGLEGPEDEYEGNKDAERALIRVKQKLDGYEGGEMRSVHGQVQQLIQDAIDPERFCLMFPGWGAWL

***VVDWHSDHDIVHAVWTLVHMCCSDDASSIRAWVSDFISRVGIGDPHCVVFHLPRDSIYMHACRPINHGSGSATEFNFHLDAGISEELLIAVLKILKKYLMDDSVQIVDMTSQTLRGILSTEKGQRAVMSFDSYERSLLEVHSKGVNVELVETFLLDLERKFKANGISPEKSTVWETDGKTFETWICPLTYSLIGCCNDVVLRLCQDIVLLKSEVAELLLPSVVVNLAGSKNVDVDLQKLISSQVQKYIFTESNKLIKSIQVFLNALNELRLCHVM***************************************NATMTTSWDKVYWLSVDYLRVAKSAVICGSYFTSVMYVEHWCEEHYKSLTLGSPDFSHLETLPRHIEILVSAVTQINEPDSLYGIIQSHKLSSQIVTLEHEGNWSKALEYYELQVRSDVML************************************LMRSLQQVGCMHVLDMYCKGLTSWKGQFQHDPEFTKLQYEAAWRTGNWDFSLPYLGANFPSGQNIKSGHFHENLHSCLTALREGDSEEFYRKLKHSKQELVLSVACASEESTEYIYSAIVKLQILCHLGVAWDIRWKSSGESINIYPEKQKIVSEPVIPTVGQLSWLNTEWSSILKRTQLHMNLLEPFMAFRRVLLQILSCKDFTMQHLLESASTLRKGFRLSQAAAALHELKFLYTGPGDQCSTVYWLGRLEEAKLLRAQGQHEMAINLAKYISENYESNEEAPDVYRLVGKWLAESR**NSRIILENYLKPAV***************RQCQTHFHLAHYADALFKSYEERLASNEWQAAMRLRKHKTIELEALIKR********************************LLDDRDNFLGLALEGYKRCLVIGDKYDVRVVFRLVSLWFSLSSRQNVIKNMVDTIDELLALANGDRI*********FVVDMDKKLAAENLLEELSSYHGAIIRQMKQMVDVYIKLAELETRREDTNKRIQLPREIRCLRQLELVPVVTATVPIDCTCQYNEGSFPYFKGLAESVMVMNGINAPKVVECFGSDGHKYRQLAK***DDLRQDAVMEQFFGLVNTFLRNHRDTWKRRLGVRTYKVVPFTPSAGILEWVDGTVPLGDYLIGSTRNGGAHGRYGIGDWSFLKCREHMSNVKDKRIAFQEVCENFRPVLHYFFLERFLQPAYWFEKRLAYTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFEQGLMLKTPERVPFRLTRDIIDGMGVTGVEGVFRRCCEKTLSVMRTNKEALLTIVEVFIHDPLYKWALSPLK******************************************Y******SVHGQVQQLIQDAIDPERFCLMFPGWGAW*

*EE***WHSDHDIVHAVWTLVHMCCSDDASSIRAWVSDFISRVGIGDPHCVVFHLPRDSIYMH*************EFNFHLDAGISEELLIAVLKILKKYLMDDSVQIVDMTSQTLRGILSTEKGQRAVMSFDSYERSLLEVHSKGVNVELVETFLLDLE**F****ISPEKSTVWETDGKTFETWICPLTYSLIGCCNDVVLRLCQDIVLLKSEVAELLLPSVVVNLAGSKNVDVDLQKLISSQVQKYIF************FLNALNELRLCHVMERSSSVPPKRESSKYVKHS*******************SNATMTTSWDKVYWLSVDYLRVAKSAVICGSYFTSVMYVEHWCE*******************PRHIEILVSAVTQINEPDSLYGIIQSHKLS********EGNWSKALEYYELQVRS**********GALSPHGLPSVHLSPSTSENEMMQRKPYKGLMRSLQQVGCMHVLDMYCKGLTSWKGQFQHDPEFTKLQYEAAWRTGNWDFSLPYLGA********KSGHFHENLHSCLTALREGDSEEFYRKLKHSKQELVLSVACASEESTEYIYSAIVKLQILCHLGVAWDIRWKSSGE***IYPEKQKIVSEPVIPTVGQLSWLNTEWSSILKRTQLHMNLLEPFMAFRRVLLQILSCKDFTMQHLLESASTLRKGFRLSQAAAALHELKFLY*****QCSTVYWLGRLEEAKLLRAQGQHEMAINLAKYISENYESNEEAPDVYRLVGKWLAESRSSNSRIILENYLKPAVSFSEDQRTTDKKSIERQCQTHFHLAHYADALFKSYEER*****WQAAMRLRKHKTIELEALIKRLKSSTKGEKTDYSIKIQELQKQLAMDREE*******RDNFLGLALEGYKRCLVIGDKYDVRVVFRLVSLWFSLSSRQNVIKNMVDTIDELLALANGDRIKDKQRSRNSFVVDMDKKLAAENLLEELSSYHGAIIRQMKQMVDVYIKLAELE*******************RQLELVPVVTATVP*****QYNEGSFPYFKGLAESVMVMNGINAPKVVECFGSDGHKYRQLAKSGNDDLRQDAVMEQFFGLVNTFLRNHRDTWKRRLGVRTYKVVPFTPSAGILEWVDGTVPLGDYLIGSTRNGG****YGIGDWSFLKCREHMSNVKDKRIAFQEVCENFRPVLHYFFLERFLQPAYWFEKRLAYTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFEQGLMLKTPERVPFRLTRDIIDGMGVTGVEGVFRRCCEKTLSVMRTNKEALLTIVEVFIHDPLYKW***************************EYEGNKDAERALIRVKQKLDGYEGGEMRSVHGQVQQLIQDAIDPERFCLMFPGWGAWL

********SDHDIVHAVWTLVHMCCSDDASSIRAWVSDFISRVGIGDPHCVVFHLPRDSIYMHACRPINHGSGSATEFNFHLDAGISEELLIAVLKILKKYLMDDSVQIVDMTSQTLRGILSTEKGQRAVMSFDSYERSLLEVHSKGVNVELVETFLLDLERKFKANGISPEKSTVWETDGKTFETWICPLTYSLIGCCNDVVLRLCQDIVLLKSEVAELLLPSVVVNLAGSKNVDVDLQKLISSQVQKYIFTESNKLIKSIQVFLNALNELRLCHVME*************************************SNATMTTSWDKVYWLSVDYLRVAKSAVICGSYFTSVMYVEHWCEEHYKSLTLGSPDFSHLETLPRHIEILVSAVTQINEPDSLYGIIQSHKLSSQIVTLEHEGNWSKALEYYELQVRSDVMLQMDGNSGALSPHGLPSVHLSPSTSENEMMQRKPYKGLMRSLQQVGCMHVLDMYCKGLTSWKGQFQHDPEFTKLQYEAAWRTGNWDFSLPYLGANFPSGQNIKSGHFHENLHSCLTALREGDSEEFYRKLKHSKQELVLSVACASEESTEYIYSAIVKLQILCHLGVAWDIRWKSSGESINIYPEKQKIVSEPVIPTVGQLSWLNTEWSSILKRTQLHMNLLEPFMAFRRVLLQILSCKDFTMQHLLESASTLRKGFRLSQAAAALHELKFLYTGPGDQCSTVYWLGRLEEAKLLRAQGQHEMAINLAKYISENYESNEEAPDVYRLVGKWLAESRSSNSRIILENYLKPAVS*************ERQCQTHFHLAHYADALFKSYEERLASNEWQAAMRLRKHKTIELEALIKRLK********DYSIKIQELQKQLAMDREEAQKLLDDRDNFLGLALEGYKRCLVIGDKYDVRVVFRLVSLWFSLSSRQNVIKNMVDTIDELLALANGDRIKDKQRSRNSFVVDMDKKLAAENLLEELSSYHGAIIRQMKQMVDVYIKLAELETRREDTNKRIQLPREIRCLRQLELVPVVTATVPIDCTCQYNEGSFPYFKGLAESVMVMNGINAPKVVECFGSDGHKYRQLAKSGNDDLRQDAVMEQFFGLVNTFLRNHRDTWKRRLGVRTYKVVPFTPSAGILEWVDGTVPLGDYLIGSTRNGGAHGRYGIGDWSFLKCREHMSNVKDKRIAFQEVCENFRPVLHYFFLERFLQPAYWFEKRLAYTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFEQGLMLKTPERVPFRLTRDIIDGMGVTGVEGVFRRCCEKTLSVMRTNKEALLTIVEVFIHDPLYKWALSPLKALQRQKEMDDDLETGLEGPEDEYEGNKDAERALIRVKQKLDGYEGGEMRSVHGQVQQLIQDAIDPERFCLMFPGWGAWL

MEEVVDWHSDHDIVHAVWTLVHMCCSDDASSIRAWVSDFISRVGIGDPHCVVFHLPRDSIYMHACRPINHGSGSATEFNFHLDAGISEELLIAVLKILKKYLMDDSVQIVDMTSQTLRGILSTEKGQRAVMSFDSYERSLLEVHSKGVNVELVETFLLDLERKFKANGISPEKSTVWETDGKTFETWICPLTYSLIGCCNDVVLRLCQDIVLLKSEVAELLLPSVVVNLAGSKNVDVDLQKLISSQVQKYIFTESNKLIKSIQVFLNALNELRLCHVMERSSSVP*KRE**************RSTSAKARDVVATSNATMTTSWDKVYWLSVDYLRVAKSAVICGSYFTSVMYVEHWCEEHYKSLTLG*PDFSHLETLPRHIEILVSAVTQINEPDSLYGIIQSHKLSSQIVTLEHEGNWSKALEYYELQVRSDVMLQMDGNSGALSPHGLPSVHLSPSTSENEMMQRKPYKGLMRSLQQVGCMHVLDMYCKGLTSWKGQFQHDPEFTKLQYEAAWRTGNWDFSLPYLGANFPSGQNIKSGHFHENLHSCLTALREGDSEEFYRKLKHSKQELVLSVACASEESTEYIYSAIVKLQILCHLGVAWDIRWKSSGESINIYPEKQKIVSEPVIPTVGQLSWLNTEWSSILKRTQLHMNLLEPFMAFRRVLLQILSCKDFTMQHLLESASTLRKGFRLSQAAAALHELKFLYTGPGDQCSTVYWLGRLEEAKLLRAQGQHEMAINLAKYISENYESNEEAPDVYRLVGKWLAESRSSNSRIILENYLKPAVSFSEDQRTTDKKSIERQCQTHFHLAHYADALFKSYEERLASNEWQAAMRLRKHKTIELEALIKRLKSSTKGEKTDYSIKIQELQKQLAMDREEAQKLLDDRDNFLGLALEGYKRCLVIGDKYDVRVVFRLVSLWFSLSSRQNVIKNMVDTIDELLALANGDRIKDKQRSRNSFVVDMDKKLAAENLLEELSSYHGAIIRQMKQMVDVYIKLAELETRREDTNKRIQLPREIRCLRQLELVPVVTATVPIDCTCQYNEGSFPYFKGLAESVMVMNGINAPKVVECFGSDGHKYRQLAKSGNDDLRQDAVMEQFFGLVNTFLRNHRDTWKRRLGVRTYKVVPFTPSAGILEWVDGTVPLGDYLIGSTRNGGAHGRYGIGDWSFLKCREHMSNVKDKRIAFQEVCENFRPVLHYFFLERFLQPAYWFEKRLAYTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFEQGLMLKTPERVPFRLTRDIIDGMGVTGVEGVFRRCCEKTLSVMRTNKEALLTIVEVFIHDPLYKWALSPLKA**********************EGNKDAERALIRVKQKLDGYEGGEMRSVHGQVQQLIQDAIDPERFCLMFPGWGAWL

oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo

oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii

ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo

xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

MEEVVDWHSDHDIVHAVWTLVHMCCSDDASSIRAWVSDFISRVGIGDPHCVVFHLPRDSIYMHACRPINHGSGSATEFNFHLDAGISEELLIAVLKILKKYLMDDSVQIVDMTSQTLRGILSTEKGQRAVMSFDSYERSLLEVHSKGVNVELVETFLLDLERKFKANGISPEKSTVWETDGKTFETWICPLTYSLIGCCNDVVLRLCQDIVLLKSEVAELLLPSVVVNLAGSKNVDVDLQKLISSQVQKYIFTESNKLIKSIQVFLNALNELRLCHVMERSSSVPPKRESSKYVKHSGSSAKPRSTSAKARDVVATSNATMTTSWDKVYWLSVDYLRVAKSAVICGSYFTSVMYVEHWCEEHYKSLTLGSPDFSHLETLPRHIEILVSAVTQINEPDSLYGIIQSHKLSSQIVTLEHEGNWSKALEYYELQVRSDVMLQMDGNSGALSPHGLPSVHLSPSTSENEMMQRKPYKGLMRSLQQVGCMHVLDMYCKGLTSWKGQFQHDPEFTKLQYEAAWRTGNWDFSLPYLGANFPSGQNIKSGHFHENLHSCLTALREGDSEEFYRKLKHSKQELVLSVACASEESTEYIYSAIVKLQILCHLGVAWDIRWKSSGESINIYPEKQKIVSEPVIPTVGQLSWLNTEWSSILKRTQLHMNLLEPFMAFRRVLLQILSCKDFTMQHLLESASTLRKGFRLSQAAAALHELKFLYTGPGDQCSTVYWLGRLEEAKLLRAQGQHEMAINLAKYISENYESNEEAPDVYRLVGKWLAESRSSNSRIILENYLKPAVSFSEDQRTTDKKSIERQCQTHFHLAHYADALFKSYEERLASNEWQAAMRLRKHKTIELEALIKRLKSSTKGExxxxxxxxxxxxxxxxxxxxxxxxxxxxRDNFLGLALEGYKRCLVIGDKYDVRVVFRLVSLWFSLSSRQNVIKNMVDTIDELLALANGDRIKDKQRSRNSFVVDMDKKLAAENLLEELSSYHGAIIRQMKQMVDVYIKLAELETRREDTNKRIQLPREIRCLRQLELVPVVTATVPIDCTCQYNEGSFPYFKGLAESVMVMNGINAPKVVECFGSDGHKYRQLAKSGNDDLRQDAVMEQFFGLVNTFLRNHRDTWKRRLGVRTYKVVPFTPSAGILEWVDGTVPLGDYLIGSTRNGGAHGRYGIGDWSFLKCREHMSNVKDKRIAFQEVCENFRPVLHYFFLERFLQPAYWFEKRLAYTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFEQGLMLKTPERVPFRLTRDIIDGMGVTGVEGVFRRCCEKTLSVMRTNKEALLTIVEVFIHDPLYKWALSPLKALQRQKEMDDDLETGLEGPEDEYEGNKDAERALIRVKQKLDGYEGGEMRSVHGQVQQLIQDAIDPERFCLMFPGWGAWL

no confident homologs detected

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Alignment graph	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query		1412	2.2.26 [Sep-21-2011]
Q9M3G7		3856	Serine/threonine-protein	yes	no	0.987	0.361	0.664	0.0
Q62388		3066	Serine-protein kinase ATM	yes	no	0.864	0.397	0.315	1e-175
Q13315		3056	Serine-protein kinase ATM	yes	no	0.858	0.396	0.315	1e-175
Q6PQD5		3057	Serine-protein kinase ATM	yes	no	0.854	0.394	0.312	1e-172
Q4IB89		2813	Serine/threonine-protein	yes	no	0.699	0.351	0.281	1e-107
O74630		2812	Serine/threonine-protein	yes	no	0.441	0.221	0.328	1e-102
Q5EAK6		2767	Serine/threonine-protein	yes	no	0.466	0.238	0.319	1e-100
Q4WVM7		2796	Serine/threonine-protein	yes	no	0.258	0.130	0.471	1e-100
Q2U639		2925	Serine/threonine-protein	yes	no	0.259	0.125	0.463	3e-98
Q7RZT9		2939	Serine/threonine-protein	N/A	no	0.262	0.125	0.433	4e-94

>sp\|Q9M3G7\|ATM_ARATH Serine/threonine-protein kinase ATM OS=Arabidopsis thaliana GN=ATM PE=2 SV=1	Back alignment and function desciption

 Score = 1987 bits (5148), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 973/1464 (66%), Positives = 1163/1464 (79%), Gaps = 69/1464 (4%)

Query: 7    WHSDHDIVHAVWTLVHMCCSDDASSIRAWVSDFISRVGIGDPHCVVFHLPRDSIYMHACR 66
            W SD +IV+AVWTLV +  SD+A S+R  VSDF+SR+GI DPH VVFHLP + + MH  +
Sbjct: 2404 WQSDDEIVNAVWTLVRVSASDEADSMRLLVSDFLSRIGIRDPHTVVFHLPGNLVSMHGLQ 2463

Query: 67   PINHGSGSATEFNFHLDAGISEELLIAVLKILKKYLMDDSVQIVDMTSQTLRGILSTEKG 126
               H +GS  +     + GIS+E LI +L  LKKYL+DDSV+I+D+TSQTLRGILSTE+G
Sbjct: 2464 GFGHNTGS--KVRSLTENGISDETLITLLNFLKKYLLDDSVKIIDVTSQTLRGILSTERG 2521

Query: 127  QRAVMSFDSYERSLLEVHSKGVNVELVETFLLDLERKFKANGISPEKSTVWETDGKTFET 186
            Q+A+ SFDS ER+L+EVH +GVN+++VE  LLD +++FKA   S E   VW TD K F+ 
Sbjct: 2522 QQALSSFDSCERALIEVHGRGVNLDIVEKILLDSQKQFKAEKFSLETPEVWSTDNKNFDR 2581

Query: 187  WICPLTYSLIGCCNDVVLRLCQDIVLLKSEVAELLLPSVVVNLAGSKNVDVDLQKLISSQ 246
            WIC L Y +I  C DV +RLCQ+I LLK+E++ELL PSVVV+LAG   +D++L  LI+SQ
Sbjct: 2582 WICQLVYCMIALCEDVPIRLCQNIALLKAEISELLFPSVVVSLAGRIGMDINLHDLITSQ 2641

Query: 247  VQKYIFTESNKLIKSIQVFLNALNELRLCHVMERS-SSVPPKRESSKYVKHSGSSAKPRS 305
            V+++IFT+SNKL KS QV LN LNELR+C+V+ERS  S   KRE     K+S S     S
Sbjct: 2642 VKEHIFTDSNKLTKSKQVMLNTLNELRMCYVLERSIFSGQTKRE-----KNSRSC----S 2692

Query: 306  TSAKARDVVATSN---ATMTTSWDKVYWLSVDYLRVAKSAVICGSYFTSVMYVEHWCEEH 362
            T+AK RDV + SN   A++TT+W+KVYWLS+DYL VA SAV+CG+Y T+ MYVE+WCEE 
Sbjct: 2693 TAAKIRDVESGSNGMAASITTNWEKVYWLSIDYLVVAGSAVVCGAYLTASMYVEYWCEEK 2752

Query: 363  YKSLTLGSPDFSHLETLPRHIEILVSAVTQINEPDSLYGIIQSHKLSSQIVTLEHEGNWS 422
            + +L+LG PDFS+ + LP H+EILVSA+T+INEPDSLYG+I S+KLS+QI+T EHEGNW+
Sbjct: 2753 FGNLSLGDPDFSYHDKLPDHVEILVSAITRINEPDSLYGVIHSNKLSAQIITFEHEGNWT 2812

Query: 423  KALEYYELQVRSDVMLQMDGNSGALSPHGL-PSVHLSPSTSENEMMQRKPYKGLMRSLQQ 481
            +ALEYY+LQ RS  M+     S  L      P+     S      +QR+P+KGL+RSLQQ
Sbjct: 2813 RALEYYDLQARSQKMVVPSSLSENLEVEQFQPTTSARHSVFGEGEVQRQPFKGLIRSLQQ 2872

Query: 482  VGCMHVLDMYCKGLTSWKGQFQHDPEFTKLQYEAAWRTGNWDFSLPYLGANFPSGQNIKS 541
             GCMHVLD+YC+GLTS +G FQ+DPEF +LQYEAAWR G WDFSL Y   +    Q+ K+
Sbjct: 2873 TGCMHVLDLYCRGLTSREGCFQYDPEFIELQYEAAWRAGKWDFSLLYPQTHCQPLQHAKN 2932

Query: 542  GHFHENLHSCLTALREGDSEEFYRKLKHSKQELVLSVACASEESTEYIYSAIVKLQILCH 601
             ++HE+LH CL AL+EGD + FY KLK +K+ELVLS++ ASEESTE+IYS +VKLQIL H
Sbjct: 2933 NNYHESLHCCLRALQEGDYDGFYGKLKDTKKELVLSISRASEESTEFIYSTVVKLQILHH 2992

Query: 602  LGVAWDIRW-KSSGESINIYPEKQKIVSEPVIPTVGQLSWLNTEWSSILKRTQLHMNLLE 660
            LG+ WD+RW  SS +S++ Y  KQ    +PVIPT+ QLSWLN +W+SI+ +TQLHM LLE
Sbjct: 2993 LGLVWDLRWTTSSHQSVHGYLVKQMACVDPVIPTMDQLSWLNKDWNSIITQTQLHMTLLE 3052

Query: 661  PFMAFRRVLLQILSCKDFTMQHLLESASTLRKGFRLSQAAAALHELKFLYTGPGDQCSTV 720
            PF+AFRRVLLQIL C+  TMQHLL+SAS LRKG R S AAA+LHE KFL      Q    
Sbjct: 3053 PFIAFRRVLLQILGCEKCTMQHLLQSASLLRKGTRFSHAAASLHEFKFLCARSNGQQPVP 3112

Query: 721  YWLGRLEEAKLLRAQGQHEMAINLAKYISENYESNEEAPDVYRLVGKWLAESRSSNSRII 780
             WLG+LEEAKLL AQG+HE++I+LA YI  NY+  EEA D+YR++GKWLAE+RSSNSR I
Sbjct: 3113 DWLGKLEEAKLLHAQGRHEVSISLANYILHNYQLKEEASDIYRVIGKWLAETRSSNSRTI 3172

Query: 781  LENYLKPAVSFSEDQRTTD-KKSIERQCQTHFHLAHYADALFKSYEERLASNEWQAAMRL 839
            LE YL+PAVS +E+Q +   K+ ++RQ QT FHLAHYADALFKSYEERL+S+EWQAA+RL
Sbjct: 3173 LEKYLRPAVSLAEEQSSKICKRLVDRQSQTWFHLAHYADALFKSYEERLSSSEWQAALRL 3232

Query: 840  RKHKTIELEALIKRLKSSTKGEKTDYSIKIQELQKQLAMDREEAQKLLDDRDNFLGLALE 899
            RKHKT ELE  IKR KSS K E++DYS+KIQ+LQKQL MD+EEA+KL  DRDNFL LALE
Sbjct: 3233 RKHKTKELEVFIKRFKSSKKAEQSDYSLKIQDLQKQLTMDKEEAEKLQVDRDNFLKLALE 3292

Query: 900  GYKRCLVIGDKYDVRVVFRLVSLWFSLSSRQNVIKNMVDTIDE----------------- 942
            GYKRCL IGDKYDVRVVFR VS+WFSL+S++NVI NM+ TI E                 
Sbjct: 3293 GYKRCLEIGDKYDVRVVFRQVSMWFSLASQKNVIDNMLSTIKEVQSYKFIPLVYQIASRL 3352

Query: 943  ----------------------------------LLALANGDRIKDKQRSRNSFVVDMDK 968
                                              LLALANGDRIKD QRSRNSFVVDMDK
Sbjct: 3353 GSSKDESGSNSFQSALVSLIRKMAIDHPYHTILQLLALANGDRIKDNQRSRNSFVVDMDK 3412

Query: 969  KLAAENLLEELSSYHGAIIRQMKQMVDVYIKLAELETRREDTNKRIQLPREIRCLRQLEL 1028
            KLAAE+LL+++S YHG +IRQMKQ+VD+YIKLAELETRREDTN+++ LPREIR ++QLEL
Sbjct: 3413 KLAAEHLLQDVSHYHGPMIRQMKQLVDIYIKLAELETRREDTNRKVALPREIRSVKQLEL 3472

Query: 1029 VPVVTATVPIDCTCQYNEGSFPYFKGLAESVMVMNGINAPKVVECFGSDGHKYRQLAKSG 1088
            VPVVTAT+P+D +CQYNEGSFP+F+GL++SV VMNGINAPKVVECFGSDG KY+QLAKSG
Sbjct: 3473 VPVVTATIPVDRSCQYNEGSFPFFRGLSDSVTVMNGINAPKVVECFGSDGQKYKQLAKSG 3532

Query: 1089 NDDLRQDAVMEQFFGLVNTFLRNHRDTWKRRLGVRTYKVVPFTPSAGILEWVDGTVPLGD 1148
            NDDLRQDAVMEQFFGLVNTFL N+RDTWKRRL VRTYKV+PFTPSAG+LEWVDGT+PLGD
Sbjct: 3533 NDDLRQDAVMEQFFGLVNTFLHNNRDTWKRRLAVRTYKVIPFTPSAGVLEWVDGTIPLGD 3592

Query: 1149 YLIGSTRNGGAHGRYGIGDWSFLKCREHMSNVKDKRIAFQEVCENFRPVLHYFFLERFLQ 1208
            YLIGS+R+ GAHGRYGIG+W + KCREHMS+ KDKR AF +VC NFRPV+HYFFLE+FLQ
Sbjct: 3593 YLIGSSRSEGAHGRYGIGNWKYPKCREHMSSAKDKRKAFVDVCTNFRPVMHYFFLEKFLQ 3652

Query: 1209 PAYWFEKRLAYTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFEQGLMLK 1268
            PA WF KRLAYTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFEQGLMLK
Sbjct: 3653 PADWFVKRLAYTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFEQGLMLK 3712

Query: 1269 TPERVPFRLTRDIIDGMGVTGVEGVFRRCCEKTLSVMRTNKEALLTIVEVFIHDPLYKWA 1328
            TPERVPFRLTRDIIDGMG+TGVEGVFRRCCE+TLSVMRTNKEALLTIVEVFIHDPLYKWA
Sbjct: 3713 TPERVPFRLTRDIIDGMGITGVEGVFRRCCEETLSVMRTNKEALLTIVEVFIHDPLYKWA 3772

Query: 1329 LSPLKALQRQKEMDDDLETGLEGPEDEYEGNKDAERALIRVKQKLDGYEGGEMRSVHGQV 1388
            LSPLKALQRQKE +D     LEG ++E+EGNKDA RAL+RVKQKLDGYEGGEMRS+HGQ 
Sbjct: 3773 LSPLKALQRQKETEDYDGMNLEGLQEEFEGNKDATRALMRVKQKLDGYEGGEMRSIHGQA 3832

Query: 1389 QQLIQDAIDPERFCLMFPGWGAWL 1412
            QQLIQDAID +R   MFPGWGAW+
Sbjct: 3833 QQLIQDAIDTDRLSHMFPGWGAWM 3856

Serine/threonine protein kinase which activates checkpoint signaling upon genotoxic stresses such as ionizing radiation (IR) or DNA replication stalling. Plays a central role in the perception and response to both stress-induced damage in somatic cells and developmentally programmed DNA damage during meiosis. Recognizes the substrate consensus sequence [ST]-Q. Phosphorylates histone variant H2AX to form H2AXS139ph at double strand breaks (DSBs), thereby regulating DNA damage response mechanism. Involved in transcriptional regulation of RAD51, PARP1, GR1, and LIG4 in response to DNA double strand breaks. Plays a dual role by activating the DNA damage response at dysfunctional telomeres and yet preventing this activation at functional telomeres. Not required for telomere length homeostasis.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp\|Q62388\|ATM_MOUSE Serine-protein kinase ATM OS=Mus musculus GN=Atm PE=1 SV=2	Back alignment and function description

>sp\|Q13315\|ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3	Back alignment and function description

>sp\|Q6PQD5\|ATM_PIG Serine-protein kinase ATM OS=Sus scrofa GN=ATM PE=3 SV=2	Back alignment and function description

>sp\|Q4IB89\|ATM_GIBZE Serine/threonine-protein kinase TEL1 OS=Gibberella zeae (strain PH-1 / ATCC MYA-4620 / FGSC 9075 / NRRL 31084) GN=TEL1 PE=3 SV=1	Back alignment and function description

>sp\|O74630\|ATM_SCHPO Serine/threonine-protein kinase tel1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=tel1 PE=1 SV=1	Back alignment and function description

>sp\|Q5EAK6\|ATM_DROME Serine/threonine-protein kinase ATM OS=Drosophila melanogaster GN=tefu PE=2 SV=1	Back alignment and function description

>sp\|Q4WVM7\|ATM_ASPFU Serine/threonine-protein kinase tel1 OS=Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) GN=tel1 PE=3 SV=2	Back alignment and function description

>sp\|Q2U639\|ATM_ASPOR Serine/threonine-protein kinase tel1 OS=Aspergillus oryzae (strain ATCC 42149 / RIB 40) GN=tel1 PE=3 SV=1	Back alignment and function description

>sp\|Q7RZT9\|ATM_NEUCR Serine/threonine-protein kinase tel-1 OS=Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) GN=tel-1 PE=3 SV=2	Back alignment and function description

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Alignment Graph	Length	Definition	Q cover	H cover	Identity	E-value
Query		1412
359491245		2956	PREDICTED: serine/threonine-protein kina	0.983	0.469	0.754	0.0
297733786		3085	unnamed protein product [Vitis vinifera]	0.983	0.449	0.734	0.0
255540663		2954	ataxia telangiectasia mutated, putative	0.985	0.470	0.734	0.0
356507238		3439	PREDICTED: serine/threonine-protein kina	0.983	0.403	0.720	0.0
449441017		2985	PREDICTED: LOW QUALITY PROTEIN: serine/t	0.986	0.466	0.704	0.0
56748564		3856	RecName: Full=Serine/threonine-protein k	0.987	0.361	0.664	0.0
7529272		3856	ataxia-telangiectasia mutated protein (A	0.987	0.361	0.661	0.0
240255538		3845	serine/threonine-protein kinase [Arabido	0.980	0.359	0.660	0.0
297815998		3832	hypothetical protein ARALYDRAFT_323420 [	0.979	0.360	0.654	0.0
222617585		2743	hypothetical protein OsJ_00056 [Oryza sa	0.960	0.494	0.575	0.0

>gi\|359491245\|ref\|XP_002279402.2\| PREDICTED: serine/threonine-protein kinase ATM [Vitis vinifera]	Back alignment and taxonomy information

 Score = 2227 bits (5772), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 1103/1461 (75%), Positives = 1225/1461 (83%), Gaps = 73/1461 (4%)

Query: 7    WHSDHDIVHAVWTLVHMCCSDDASSIRAWVSDFISRVGIGDPHCVVFHLPRDSIYMHACR 66
            W +D DIVHAVW LVHMC SDDA+S+RA VSDFISRVGIGDPHCVVFHLP D   +H CR
Sbjct: 1514 WRADQDIVHAVWNLVHMCGSDDANSVRALVSDFISRVGIGDPHCVVFHLPGDYSQIHVCR 1573

Query: 67   PINHGSGSATEFNFHLDAGISEELLIAVLKILKKYLMDDSVQIVDMTSQTLRGILSTEKG 126
            PI+H SG+  E +F LD  ISEELL+A++++LKKYLMDDSV+I+D+TSQTL GILSTE+G
Sbjct: 1574 PIHHDSGA--EISFPLDTSISEELLLALMRLLKKYLMDDSVKIIDLTSQTLWGILSTERG 1631

Query: 127  QRAVMSFDSYERSLLEVHSKGVNVELVETFLLDLERKFKANGISPEKSTVWETDGKTFET 186
            Q+A++SFDSYERSL+EVHSKGVNVELVE  L DLE+KF A  I  EKST+W+T  KTFE 
Sbjct: 1632 QKALLSFDSYERSLIEVHSKGVNVELVEKLLSDLEKKFNAEAIPLEKSTIWKTHEKTFEM 1691

Query: 187  WICPLTYSLIGCCNDVVLRLCQDIVLLKSEVAELLLPSVVVNLAGSKNVDVDLQKLISSQ 246
            WICPL +SLIG CND +LRLCQDIVLLK+EVAELLLP+V+VNLAG K++ VDL KLISSQ
Sbjct: 1692 WICPLVHSLIGFCNDTILRLCQDIVLLKAEVAELLLPNVIVNLAGRKDLAVDLCKLISSQ 1751

Query: 247  VQKYIFTESNKLIKSIQVFLNALNELRLCHVMER--SSSVPPKRESSKYVKHSGSSAKPR 304
            VQ+ IF ESN+ IKSIQV L+ALNELRL +VMER  SSS+P KRE+S+    + SS    
Sbjct: 1752 VQENIFVESNRSIKSIQVMLDALNELRLFYVMERTTSSSIPLKRETSRVNSSTMSSVALV 1811

Query: 305  STSAKARDVVATSNATMTTSWDKVYWLSVDYLRVAKSAVICGSYFTSVMYVEHWCEEHYK 364
            STS                 W+KVYWLS+DYL VAKSA+ICGSYFTSVMYVEHWCEEH+ 
Sbjct: 1812 STSL----------------WEKVYWLSIDYLDVAKSAIICGSYFTSVMYVEHWCEEHFN 1855

Query: 365  SLTLGSPDFSHLETLPRHIEILVSAVTQINEPDSLYGIIQSHKLSSQIVTLEHEGNWSKA 424
            SLTLG PDFSH E LP HIEILVSA+TQINEPDSLYGIIQ HKL+SQI+T EHEGNWSKA
Sbjct: 1856 SLTLGKPDFSHCEMLPHHIEILVSAITQINEPDSLYGIIQLHKLTSQIITFEHEGNWSKA 1915

Query: 425  LEYYELQVRSDVMLQMDGNSGALSP-HGLPSVHLSPSTSENEMMQRKPYKGLMRSLQQVG 483
            LEYY+LQVRS+ +  MDG+S  LSP H   +VH S S SE+ + QR+PYKGL+RSLQ++G
Sbjct: 1916 LEYYDLQVRSEPVAGMDGSSRNLSPEHSQLTVHPSFSKSEDVIRQREPYKGLIRSLQKIG 1975

Query: 484  CMHVLDMYCKGLTSWKGQFQHDPEFTKLQYEAAWRTGNWDFSLPYLGANFPSG-QNIKSG 542
            C HVLD+YC+GLTS  GQFQHD EFT+LQYEAAWR GNWDFSL Y+GAN PS  Q+I+  
Sbjct: 1976 CTHVLDLYCQGLTSQNGQFQHDLEFTELQYEAAWRAGNWDFSLLYMGANSPSSSQHIRCD 2035

Query: 543  HFHENLHSCLTALREGDSEEFYRKLKHSKQELVLSVACASEESTEYIYSAIVKLQILCHL 602
            HF+ENLHSCL A +EGD  EF+ KLK SKQELVLSV  AS +STEYIYS I+KLQI  HL
Sbjct: 2036 HFNENLHSCLRAFQEGDFNEFHSKLKDSKQELVLSVCHASGQSTEYIYSTIIKLQIFYHL 2095

Query: 603  GVAWDIRWKSSGESINIYPEKQKIVSEPVIPTVGQLSWLNTEWSSILKRTQLHMNLLEPF 662
            G+AW +RW    E I   P  QK+ SEP+IPT+ QLSWLNT+WSSILKRTQLHMNLLEPF
Sbjct: 2096 GMAWGLRWAPPSEKIETSPGMQKVFSEPIIPTMDQLSWLNTDWSSILKRTQLHMNLLEPF 2155

Query: 663  MAFRRVLLQILSCKDFTMQHLLESASTLRKGFRLSQAAAALHELKFLYTGPGDQCSTVYW 722
            +AFRRVLLQILS KD  +QHLL+S+STLRKG R SQAAAALHE KFL    G+Q S  YW
Sbjct: 2156 IAFRRVLLQILSSKDCMVQHLLQSSSTLRKGSRFSQAAAALHEFKFLCNRMGEQHSASYW 2215

Query: 723  LGRLEEAKLLRAQGQHEMAINLAKYISENYESNEEAPDVYRLVGKWLAESRSSNSRIILE 782
            LGRLEEAKLLRAQGQHEMAINLAKYIS+N + NEEA +VYRLVGKWLAE+RSSNSR ILE
Sbjct: 2216 LGRLEEAKLLRAQGQHEMAINLAKYISQNSQLNEEASNVYRLVGKWLAETRSSNSRTILE 2275

Query: 783  NYLKPAVSFSEDQRTTDKKSIERQCQTHFHLAHYADALFKSYEERLASNEWQAAMRLRKH 842
             YLK AV  ++D + TDKK+IERQ QTHFHLAHYADALF+S+EERLASNEWQAA RLRKH
Sbjct: 2276 KYLKRAVLLAKDNKNTDKKTIERQSQTHFHLAHYADALFRSHEERLASNEWQAATRLRKH 2335

Query: 843  KTIELEALIKRLKSSTKGEKTDYSIKIQELQKQLAMDREEAQKLLDDRDNFLGLALEGYK 902
            KTIELEALIKRL+SS+KGEKTDYS+KIQELQKQLAMD EEA+KL DDRDNFL L LEGYK
Sbjct: 2336 KTIELEALIKRLRSSSKGEKTDYSVKIQELQKQLAMDAEEAEKLQDDRDNFLSLTLEGYK 2395

Query: 903  RCLVIGDKYDVRVVFRLVSLWFSLSSRQNVIKNMVDTIDE-------------------- 942
            RCLV+GDKYDVRVVFRLVSLWFSLSSRQNVI  M+ T+ E                    
Sbjct: 2396 RCLVLGDKYDVRVVFRLVSLWFSLSSRQNVINMMLSTVQEVQSYKFIPLVYQIASRMGSS 2455

Query: 943  -------------------------------LLALANGDRIKDKQRSRNSFVVDMDKKLA 971
                                           LLALANGDRIKDKQRSRNSFVVDMDKKLA
Sbjct: 2456 KDGLGPHSFQFALVSLVKKMSIDHPYHTIFQLLALANGDRIKDKQRSRNSFVVDMDKKLA 2515

Query: 972  AENLLEELSSYHGAIIRQMKQMVDVYIKLAELETRREDTNKRIQLPREIRCLRQLELVPV 1031
            AENLL+ELSS HG+II+QMKQMV++YIKLAELET+REDTNKR+ LPREIR LRQLELVPV
Sbjct: 2516 AENLLKELSSCHGSIIQQMKQMVEIYIKLAELETKREDTNKRVMLPREIRSLRQLELVPV 2575

Query: 1032 VTATVPIDCTCQYNEGSFPYFKGLAESVMVMNGINAPKVVECFGSDGHKYRQLAKSGNDD 1091
            VT+T P+D  CQY+EGSFP+FKGL +SVM+MNGINAPKVVEC GSDG KYRQLAKSGNDD
Sbjct: 2576 VTSTFPVDRNCQYHEGSFPHFKGLGDSVMIMNGINAPKVVECLGSDGQKYRQLAKSGNDD 2635

Query: 1092 LRQDAVMEQFFGLVNTFLRNHRDTWKRRLGVRTYKVVPFTPSAGILEWVDGTVPLGDYLI 1151
            LRQDAVMEQFF LVNTFL NHRDTWKRRL VRTYKVVPFTPSAG+LEWV+GT+PLG+YLI
Sbjct: 2636 LRQDAVMEQFFSLVNTFLENHRDTWKRRLRVRTYKVVPFTPSAGVLEWVNGTLPLGEYLI 2695

Query: 1152 GSTRNGGAHGRYGIGDWSFLKCREHMSNVKDKRIAFQEVCENFRPVLHYFFLERFLQPAY 1211
            GSTRNGGAHGRYG+ DWSF KCREHM+N KDKR AFQEVC+NFRPV+H FFLERFLQPA 
Sbjct: 2696 GSTRNGGAHGRYGMEDWSFSKCREHMTNEKDKRKAFQEVCKNFRPVMHNFFLERFLQPAD 2755

Query: 1212 WFEKRLAYTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFEQGLMLKTPE 1271
            WFEKRLAYTRSVAASSMVGYIVGLGDRH+MNILIDQATAEVVHIDLGVAFEQGLMLKTPE
Sbjct: 2756 WFEKRLAYTRSVAASSMVGYIVGLGDRHSMNILIDQATAEVVHIDLGVAFEQGLMLKTPE 2815

Query: 1272 RVPFRLTRDIIDGMGVTGVEGVFRRCCEKTLSVMRTNKEALLTIVEVFIHDPLYKWALSP 1331
            RVPFRLTRDIIDGMGVTGVEGVFRRCCE+TLSVMRTNKEALLTIVEVFIHDPLYKWALSP
Sbjct: 2816 RVPFRLTRDIIDGMGVTGVEGVFRRCCEETLSVMRTNKEALLTIVEVFIHDPLYKWALSP 2875

Query: 1332 LKALQRQKEMDDDLETGLEGPEDEYEGNKDAERALIRVKQKLDGYEGGEMRSVHGQVQQL 1391
            LKALQRQKE DDDLET LE  E+EYEGNKDA RAL+RVKQKLDGYE GEMRSVHGQV+QL
Sbjct: 2876 LKALQRQKETDDDLETSLEDLEEEYEGNKDAARALLRVKQKLDGYEEGEMRSVHGQVRQL 2935

Query: 1392 IQDAIDPERFCLMFPGWGAWL 1412
            IQDAIDP+RFC MFPGWGAWL
Sbjct: 2936 IQDAIDPDRFCRMFPGWGAWL 2956

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Class:

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi\|297733786\|emb\|CBI15033.3\| unnamed protein product [Vitis vinifera]	Back alignment and taxonomy information

>gi\|255540663\|ref\|XP_002511396.1\| ataxia telangiectasia mutated, putative [Ricinus communis] gi\|223550511\|gb\|EEF51998.1\| ataxia telangiectasia mutated, putative [Ricinus communis]	Back alignment and taxonomy information

>gi\|356507238\|ref\|XP_003522376.1\| PREDICTED: serine/threonine-protein kinase ATM-like [Glycine max]	Back alignment and taxonomy information

>gi\|449441017\|ref\|XP_004138280.1\| PREDICTED: LOW QUALITY PROTEIN: serine/threonine-protein kinase ATM-like [Cucumis sativus]	Back alignment and taxonomy information

>gi\|56748564\|sp\|Q9M3G7.1\|ATM_ARATH RecName: Full=Serine/threonine-protein kinase ATM; AltName: Full=Ataxia telangiectasia mutated homolog; Short=AtATM gi\|7960715\|emb\|CAB92122.1\| AtATM [Arabidopsis thaliana]	Back alignment and taxonomy information

>gi\|7529272\|emb\|CAB86487.1\| ataxia-telangiectasia mutated protein (Atm) [Arabidopsis thaliana]	Back alignment and taxonomy information

>gi\|240255538\|ref\|NP_190402.6\| serine/threonine-protein kinase [Arabidopsis thaliana] gi\|332644858\|gb\|AEE78379.1\| serine/threonine-protein kinase [Arabidopsis thaliana]	Back alignment and taxonomy information

>gi\|297815998\|ref\|XP_002875882.1\| hypothetical protein ARALYDRAFT_323420 [Arabidopsis lyrata subsp. lyrata] gi\|297321720\|gb\|EFH52141.1\| hypothetical protein ARALYDRAFT_323420 [Arabidopsis lyrata subsp. lyrata]	Back alignment and taxonomy information

>gi\|222617585\|gb\|EEE53717.1\| hypothetical protein OsJ_00056 [Oryza sativa Japonica Group]	Back alignment and taxonomy information

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Alignment graph	Length	Definition	Q cover	H cover	Identity	E-value
Query		1412
MGI\|MGI:107202		3066	Atm "ataxia telangiectasia mut	0.320	0.147	0.473	5.2e-161
UNIPROTKB\|Q13315		3056	ATM "Serine-protein kinase ATM	0.330	0.152	0.473	3.3e-158
UNIPROTKB\|E1C0Q6		3069	ATM "Uncharacterized protein"	0.330	0.151	0.467	3.7e-158
UNIPROTKB\|F1PEL7		3065	ATM "Uncharacterized protein"	0.330	0.152	0.473	1.7e-157
UNIPROTKB\|Q5MPF8		3061	atm "Ataxia telangiectasia mut	0.298	0.137	0.519	2.7e-157
UNIPROTKB\|E1BEI6		3057	ATM "Uncharacterized protein"	0.330	0.152	0.477	2.4e-156
ZFIN\|ZDB-GENE-040809-1		2773	atm "ataxia telangiectasia mut	0.337	0.172	0.457	2.4e-156
RGD\|1593265		3064	Atm "ataxia telangiectasia mut	0.330	0.152	0.467	1.6e-154
UNIPROTKB\|J9JHR5		3057	ATM "Uncharacterized protein"	0.329	0.152	0.478	8.8e-154
UNIPROTKB\|Q6PQD5		3057	ATM "Serine-protein kinase ATM	0.330	0.152	0.461	2e-153

MGI\|MGI:107202 Atm "ataxia telangiectasia mutated homolog (human)" [Mus musculus (taxid:10090)]	Back alignment and assigned GO terms

 Score = 1089 (388.4 bits), Expect = 5.2e-161, Sum P(4) = 5.2e-161
 Identities = 226/477 (47%), Positives = 307/477 (64%)

Query:   955 KQRSRNSFVVDMDKKXXXXXXXXXXSSYHGAIIRQMKQMVDVYIKLAELETRR-EDTNKR 1013
             K  S+ +  +D D+            S    +++ M+ + D YI LA ++  +     K 
Sbjct:  2595 KSTSKENSHLDEDRTEAATRIIHSIRSKRCKMVKDMEALCDAYIILANMDASQWRAQRKG 2654

Query:  1014 IQLP--REIRCLRQLELVPVVTATVPIDCTCQYNEGSFPYFKGLAESVMVMNGINAPKVV 1071
             I +P  + I  L+ LE V V T  + +D T +Y   +    K       +  G+N PK++
Sbjct:  2655 INIPANQPITKLKNLEDVVVPTMEIKVDPTGEYE--NLVTIKSFKTEFRLAGGLNLPKII 2712

Query:  1072 ECFGSDGHKYRQLAKSGNDDLRQDAVMEQFFGLVNTFLRNHRDTWKRRLGVRTYKVVPFT 1131
             +C GSDG + RQL K G DDLRQDAVM+Q F + NT L+ + +T KR+L + TYKVVP +
Sbjct:  2713 DCVGSDGKERRQLVK-GRDDLRQDAVMQQVFQMCNTLLQRNTETRKRKLTICTYKVVPLS 2771

Query:  1132 PSAGILEWVDGTVPLGDYLIGSTRNGGAHGRYGIGDWSFLKCREHMSNVKDKRI-----A 1186
               +G+LEW  GTVP+G+YL+ S    GAH RY   D+S  +C++ M  V+ K        
Sbjct:  2772 QRSGVLEWCTGTVPIGEYLVNS--EDGAHRRYRPNDFSANQCQKKMMEVQKKSFEEKYDT 2829

Query:  1187 FQEVCENFRPVLHYFFLERFLQPAYWFEKRLAYTRSVAASSMVGYIVGLGDRHAMNILID 1246
             F  +C+NF PV  YF +E+FL PA WFEKRLAYTRSVA SS+VGYI+GLGDRH  NILI+
Sbjct:  2830 FMTICQNFEPVFRYFCMEKFLDPAVWFEKRLAYTRSVATSSIVGYILGLGDRHVQNILIN 2889

Query:  1247 QATAEVVHIDLGVAFEQGLMLKTPERVPFRLTRDIIDGMGVTGVEGVFRRCCEKTLSVMR 1306
             + +AE+VHIDLGVAFEQG +L TPE VPFRL+RDI+DGMG+TGVEGVFRRCCEKT+ VMR
Sbjct:  2890 EQSAELVHIDLGVAFEQGKILPTPETVPFRLSRDIVDGMGITGVEGVFRRCCEKTMEVMR 2949

Query:  1307 TNKEALLTIVEVFIHDPLYKWALSPLKAL--QRQKEMDDDLETGLEGPEDEYEG------ 1358
             +++E LLTIVEV ++DPL+ W ++PLKAL  Q++ E + DL +     + E +       
Sbjct:  2950 SSQETLLTIVEVLLYDPLFDWTMNPLKALYLQQRPEDESDLHSTPNADDQECKQSLSDTD 3009

Query:  1359 ---NKDAERALIRVKQKLDGYEGGEMRSVHGQVQQLIQDAIDPERFCLMFPGWGAWL 1412
                NK AER L+R+++KL G E G + SV GQV  LIQ A+DP+    +FPGW AW+
Sbjct:  3010 QSFNKVAERVLMRLQEKLKGVEEGTVLSVGGQVNLLIQQAMDPKNLSRLFPGWKAWV 3066

GO:0000077 "DNA damage checkpoint" evidence=IMP

GO:0000166 "nucleotide binding" evidence=IEA

GO:0000723 "telomere maintenance" evidence=IEA

GO:0001666 "response to hypoxia" evidence=ISO

GO:0001756 "somitogenesis" evidence=IGI

GO:0002331 "pre-B cell allelic exclusion" evidence=IMP

GO:0003677 "DNA binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IDA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=ISO

GO:0004677 "DNA-dependent protein kinase activity" evidence=ISO

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO;TAS

GO:0005737 "cytoplasm" evidence=ISO

GO:0005819 "spindle" evidence=IDA

GO:0006281 "DNA repair" evidence=IDA;IMP

GO:0006468 "protein phosphorylation" evidence=IDA;TAS

GO:0006974 "response to DNA damage stimulus" evidence=ISO;TAS

GO:0006975 "DNA damage induced protein phosphorylation" evidence=ISO

GO:0007049 "cell cycle" evidence=IEA

GO:0007050 "cell cycle arrest" evidence=ISO

GO:0007094 "mitotic spindle assembly checkpoint" evidence=ISO

GO:0007292 "female gamete generation" evidence=IMP

GO:0007420 "brain development" evidence=IGI

GO:0007507 "heart development" evidence=IGI

GO:0008630 "intrinsic apoptotic signaling pathway in response to DNA damage" evidence=IGI;IMP

GO:0010212 "response to ionizing radiation" evidence=ISO;IGI

GO:0016301 "kinase activity" evidence=IEA

GO:0016303 "1-phosphatidylinositol-3-kinase activity" evidence=ISO

GO:0016310 "phosphorylation" evidence=IEA

GO:0016572 "histone phosphorylation" evidence=ISO

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016773 "phosphotransferase activity, alcohol group as acceptor" evidence=IEA

GO:0018105 "peptidyl-serine phosphorylation" evidence=ISO

GO:0030889 "negative regulation of B cell proliferation" evidence=ISO

GO:0031410 "cytoplasmic vesicle" evidence=IEA

GO:0031572 "G2 DNA damage checkpoint" evidence=ISO

GO:0032403 "protein complex binding" evidence=ISO

GO:0035174 "histone serine kinase activity" evidence=ISO

GO:0035404 "histone-serine phosphorylation" evidence=ISO

GO:0036092 "phosphatidylinositol-3-phosphate biosynthetic process" evidence=ISO

GO:0042159 "lipoprotein catabolic process" evidence=IGI

GO:0043065 "positive regulation of apoptotic process" evidence=ISO

GO:0043066 "negative regulation of apoptotic process" evidence=IMP

GO:0043517 "positive regulation of DNA damage response, signal transduction by p53 class mediator" evidence=ISO

GO:0043525 "positive regulation of neuron apoptotic process" evidence=IGI

GO:0046777 "protein autophosphorylation" evidence=ISO

GO:0046983 "protein dimerization activity" evidence=ISO

GO:0047485 "protein N-terminus binding" evidence=ISO

GO:0051402 "neuron apoptotic process" evidence=IGI

GO:0051726 "regulation of cell cycle" evidence=ISO

GO:0071044 "histone mRNA catabolic process" evidence=ISO

GO:0071480 "cellular response to gamma radiation" evidence=ISO

GO:0090399 "replicative senescence" evidence=ISO

UNIPROTKB\|Q13315 ATM "Serine-protein kinase ATM" [Homo sapiens (taxid:9606)]	Back alignment and assigned GO terms

UNIPROTKB\|E1C0Q6 ATM "Uncharacterized protein" [Gallus gallus (taxid:9031)]	Back alignment and assigned GO terms

UNIPROTKB\|F1PEL7 ATM "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]	Back alignment and assigned GO terms

UNIPROTKB\|Q5MPF8 atm "Ataxia telangiectasia mutated" [Xenopus laevis (taxid:8355)]	Back alignment and assigned GO terms

UNIPROTKB\|E1BEI6 ATM "Uncharacterized protein" [Bos taurus (taxid:9913)]	Back alignment and assigned GO terms

ZFIN\|ZDB-GENE-040809-1 atm "ataxia telangiectasia mutated" [Danio rerio (taxid:7955)]	Back alignment and assigned GO terms

RGD\|1593265 Atm "ataxia telangiectasia mutated" [Rattus norvegicus (taxid:10116)]	Back alignment and assigned GO terms

UNIPROTKB\|J9JHR5 ATM "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]	Back alignment and assigned GO terms

UNIPROTKB\|Q6PQD5 ATM "Serine-protein kinase ATM" [Sus scrofa (taxid:9823)]	Back alignment and assigned GO terms

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Alignment Graph	Length	Definition	E-value
Query		1412
cd05171		279	cd05171, PIKKc_ATM, Ataxia telangiectasia mutated	1e-173
cd00892		237	cd00892, PIKKc_ATR, ATR (Ataxia telangiectasia and	1e-88
cd05164		222	cd05164, PIKKc, Phosphoinositide 3-kinase-related	8e-83
cd05169		280	cd05169, PIKKc_TOR, TOR (Target of rapamycin), cat	3e-75
COG5032		2105	COG5032, TEL1, Phosphatidylinositol kinase and pro	2e-71
smart00146		240	smart00146, PI3Kc, Phosphoinositide 3-kinase, cata	1e-67
cd00142		219	cd00142, PI3Kc_like, Phosphoinositide 3-kinase (PI	1e-60
pfam00454		233	pfam00454, PI3_PI4_kinase, Phosphatidylinositol 3-	4e-53
cd05172		235	cd05172, PIKKc_DNA-PK, DNA-dependent protein kinas	6e-53
cd05170		307	cd05170, PIKKc_SMG1, Suppressor of morphogenetic e	1e-45
cd00896		350	cd00896, PI3Kc_III, Phosphoinositide 3-kinase (PI3	2e-13
pfam02259		350	pfam02259, FAT, FAT domain	8e-13
cd05167		311	cd05167, PI4Kc_III_alpha, Phosphoinositide 4-kinas	8e-13
cd05168		293	cd05168, PI4Kc_III_beta, Phosphoinositide 4-kinase	1e-12
cd05170		307	cd05170, PIKKc_SMG1, Suppressor of morphogenetic e	3e-12
cd00891		352	cd00891, PI3Kc, Phosphoinositide 3-kinase (PI3K),	5e-12
cd00893		289	cd00893, PI4Kc_III, Phosphoinositide 4-kinase (PI4	7e-12
cd05163		253	cd05163, TRRAP, TRansformation/tRanscription domai	1e-11
cd05173		362	cd05173, PI3Kc_IA_beta, Phosphoinositide 3-kinase	3e-11
pfam02260		33	pfam02260, FATC, FATC domain	6e-09
cd05165		366	cd05165, PI3Kc_I, Phosphoinositide 3-kinase (PI3K)	1e-08
cd05174		361	cd05174, PI3Kc_IA_delta, Phosphoinositide 3-kinase	2e-06
cd00894		365	cd00894, PI3Kc_IB_gamma, Phosphoinositide 3-kinase	9e-06
cd05166		353	cd05166, PI3Kc_II, Phosphoinositide 3-kinase (PI3K	5e-05
cd05175		366	cd05175, PI3Kc_IA_alpha, Phosphoinositide 3-kinase	5e-04

>gnl\|CDD\|119431 cd05171, PIKKc_ATM, Ataxia telangiectasia mutated (ATM), catalytic domain; The ATM catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases	Back alignment and domain information

 Score =  516 bits (1332), Expect = e-173
 Identities = 181/283 (63%), Positives = 221/283 (78%), Gaps = 9/283 (3%)

Query: 1052 FKGLAESVMVMNGINAPKVVECFGSDGHKYRQLAKSGNDDLRQDAVMEQFFGLVNTFLRN 1111
                 +      GINAPK++ C GSDG KY+QL K G+DD RQDAVMEQ F LVNT L  
Sbjct: 1    VSKFKDVFTTAGGINAPKIITCVGSDGKKYKQLLKGGDDD-RQDAVMEQVFQLVNTLLER 59

Query: 1112 HRDTWKRRLGVRTYKVVPFTPSAGILEWVDGTVPLGDYLIGSTRNGGAHGRYGIGDWSFL 1171
            +++T KR+L +RTYKVVP +P AGILEWVDGT+PLG+YL+G+T   GAH RY  GDW+  
Sbjct: 60   NKETRKRKLRIRTYKVVPLSPRAGILEWVDGTIPLGEYLVGAT---GAHERYRPGDWTAR 116

Query: 1172 KCREHMSNVK-----DKRIAFQEVCENFRPVLHYFFLERFLQPAYWFEKRLAYTRSVAAS 1226
            KCR+ M+ V+     ++   F ++C+NFRPV  YFFLE+FL P  WFE+RLAYTRSVA S
Sbjct: 117  KCRKAMAEVQKESNEERLKVFLKICKNFRPVFRYFFLEKFLDPQDWFERRLAYTRSVATS 176

Query: 1227 SMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFEQGLMLKTPERVPFRLTRDIIDGMG 1286
            S+VGYI+GLGDRHA NILID+ TAEVVHIDLG+AFEQG +L  PE VPFRLTRDI+DGMG
Sbjct: 177  SIVGYILGLGDRHANNILIDEKTAEVVHIDLGIAFEQGKILPVPETVPFRLTRDIVDGMG 236

Query: 1287 VTGVEGVFRRCCEKTLSVMRTNKEALLTIVEVFIHDPLYKWAL 1329
            +TGVEGVFRRCCEKTL V+R NK+A+LTI+EV ++DPLY W +
Sbjct: 237  ITGVEGVFRRCCEKTLEVLRDNKDAILTILEVLLYDPLYSWTV 279

ATM is a member of the phosphoinositide 3-kinase-related protein kinase (PIKK) subfamily. PIKKs have intrinsic serine/threonine kinase activity and are distinguished from other PKs by their unique catalytic domain, similar to that of lipid PI3K, and their large molecular weight (240-470 kDa). ATM contains a FAT (FRAP, ATM and TRRAP) domain, a catalytic domain, and a FATC domain at the C-terminus. ATM is critical in the response to DNA double strand breaks (DSBs) caused by radiation. It is activated at the site of a DSB and phosphorylates key substrates that trigger pathways that regulate DNA repair and cell cycle checkpoints at the G1/S, S phase, and G2/M transition. Patients with the human genetic disorder Ataxia telangiectasia (A-T), caused by truncating mutations in ATM, show genome instability, increased cancer risk, immunodeficiency, compromised mobility, and neurodegeneration. A-T displays clinical heterogeneity, which is correlated to the degree of retained ATM activity. Length = 279

>gnl\|CDD\|119418 cd00892, PIKKc_ATR, ATR (Ataxia telangiectasia and Rad3-related), catalytic domain; The ATR catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases	Back alignment and domain information

>gnl\|CDD\|119424 cd05164, PIKKc, Phosphoinositide 3-kinase-related protein kinase (PIKK) subfamily, catalytic domain; The PIKK catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases	Back alignment and domain information

>gnl\|CDD\|119429 cd05169, PIKKc_TOR, TOR (Target of rapamycin), catalytic domain; The TOR catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases	Back alignment and domain information

>gnl\|CDD\|227365 COG5032, TEL1, Phosphatidylinositol kinase and protein kinases of the PI-3 kinase family [Signal transduction mechanisms / Cell division and chromosome partitioning / Chromatin structure and dynamics / DNA replication, recombination, and repair / Intracellular trafficking and secretion]	Back alignment and domain information

>gnl\|CDD\|214538 smart00146, PI3Kc, Phosphoinositide 3-kinase, catalytic domain	Back alignment and domain information

>gnl\|CDD\|119416 cd00142, PI3Kc_like, Phosphoinositide 3-kinase (PI3K)-like family, catalytic domain; The PI3K-like catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases	Back alignment and domain information

>gnl\|CDD\|189554 pfam00454, PI3_PI4_kinase, Phosphatidylinositol 3- and 4-kinase	Back alignment and domain information

>gnl\|CDD\|119432 cd05172, PIKKc_DNA-PK, DNA-dependent protein kinase (DNA-PK), catalytic domain; The DNA-PK catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases	Back alignment and domain information

>gnl\|CDD\|119430 cd05170, PIKKc_SMG1, Suppressor of morphogenetic effect on genitalia-1 (SMG-1), catalytic domain; The SMG-1 catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases	Back alignment and domain information

>gnl\|CDD\|119422 cd00896, PI3Kc_III, Phosphoinositide 3-kinase (PI3K), class III, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases	Back alignment and domain information

>gnl\|CDD\|216950 pfam02259, FAT, FAT domain	Back alignment and domain information

>gnl\|CDD\|119427 cd05167, PI4Kc_III_alpha, Phosphoinositide 4-kinase (PI4K), Type III, alpha isoform, catalytic domain; The PI4K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases	Back alignment and domain information

>gnl\|CDD\|119428 cd05168, PI4Kc_III_beta, Phosphoinositide 4-kinase (PI4K), Type III, beta isoform, catalytic domain; The PI4K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases	Back alignment and domain information

>gnl\|CDD\|119430 cd05170, PIKKc_SMG1, Suppressor of morphogenetic effect on genitalia-1 (SMG-1), catalytic domain; The SMG-1 catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases	Back alignment and domain information

>gnl\|CDD\|119417 cd00891, PI3Kc, Phosphoinositide 3-kinase (PI3K), catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases	Back alignment and domain information

>gnl\|CDD\|119419 cd00893, PI4Kc_III, Phosphoinositide 4-kinase (PI4K), Type III, catalytic domain; The PI4K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases	Back alignment and domain information

>gnl\|CDD\|119423 cd05163, TRRAP, TRansformation/tRanscription domain-Associated Protein (TRRAP), pseudokinase domain; The TRRAP catalytic domain is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases	Back alignment and domain information

>gnl\|CDD\|119433 cd05173, PI3Kc_IA_beta, Phosphoinositide 3-kinase (PI3K), class IA, beta isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases	Back alignment and domain information

>gnl\|CDD\|202180 pfam02260, FATC, FATC domain	Back alignment and domain information

>gnl\|CDD\|119425 cd05165, PI3Kc_I, Phosphoinositide 3-kinase (PI3K), class I, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases	Back alignment and domain information

>gnl\|CDD\|119434 cd05174, PI3Kc_IA_delta, Phosphoinositide 3-kinase (PI3K), class IA, delta isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases	Back alignment and domain information

>gnl\|CDD\|119420 cd00894, PI3Kc_IB_gamma, Phosphoinositide 3-kinase (PI3K), class IB, gamma isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases	Back alignment and domain information

>gnl\|CDD\|119426 cd05166, PI3Kc_II, Phosphoinositide 3-kinase (PI3K), class II, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases	Back alignment and domain information

>gnl\|CDD\|88554 cd05175, PI3Kc_IA_alpha, Phosphoinositide 3-kinase (PI3K), class IA, alpha isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases	Back alignment and domain information

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Alignment Graph	Length	Definition	Probability
Query		1412
KOG0892		2806	consensus Protein kinase ATM/Tel1, involved in tel	100.0
KOG0890		2382	consensus Protein kinase of the PI-3 kinase family	100.0
KOG0891		2341	consensus DNA-dependent protein kinase [Replicatio	100.0
COG5032		2105	TEL1 Phosphatidylinositol kinase and protein kinas	100.0
cd05171		279	PIKKc_ATM Ataxia telangiectasia mutated (ATM), cat	100.0
cd05170		307	PIKKc_SMG1 Suppressor of morphogenetic effect on g	100.0
cd05163		253	TRRAP TRansformation/tRanscription domain-Associat	100.0
cd05169		280	PIKKc_TOR TOR (Target of rapamycin), catalytic dom	100.0
cd05172		235	PIKKc_DNA-PK DNA-dependent protein kinase (DNA-PK)	100.0
cd00892		237	PIKKc_ATR ATR (Ataxia telangiectasia and Rad3-rela	100.0
cd05164		222	PIKKc Phosphoinositide 3-kinase-related protein ki	100.0
cd00142		219	PI3Kc_like Phosphoinositide 3-kinase (PI3K)-like f	100.0
cd00891		352	PI3Kc Phosphoinositide 3-kinase (PI3K), catalytic	100.0
cd00896		350	PI3Kc_III Phosphoinositide 3-kinase (PI3K), class	100.0
KOG0889		3550	consensus Histone acetyltransferase SAGA, TRRAP/TR	100.0
cd05166		353	PI3Kc_II Phosphoinositide 3-kinase (PI3K), class I	100.0
cd05177		354	PI3Kc_C2_gamma Phosphoinositide 3-kinase (PI3K), c	100.0
cd05165		366	PI3Kc_I Phosphoinositide 3-kinase (PI3K), class I,	100.0
cd05168		293	PI4Kc_III_beta Phosphoinositide 4-kinase (PI4K), T	100.0
smart00146		202	PI3Kc Phosphoinositide 3-kinase, catalytic domain.	100.0
cd00894		365	PI3Kc_IB_gamma Phosphoinositide 3-kinase (PI3K), c	100.0
cd05174		361	PI3Kc_IA_delta Phosphoinositide 3-kinase (PI3K), c	100.0
cd05176		353	PI3Kc_C2_alpha Phosphoinositide 3-kinase (PI3K), c	100.0
cd00893		289	PI4Kc_III Phosphoinositide 4-kinase (PI4K), Type I	100.0
cd05173		362	PI3Kc_IA_beta Phosphoinositide 3-kinase (PI3K), cl	100.0
PF00454		235	PI3_PI4_kinase: Phosphatidylinositol 3- and 4-kina	100.0
cd05167		311	PI4Kc_III_alpha Phosphoinositide 4-kinase (PI4K),	100.0
cd00895		354	PI3Kc_C2_beta Phosphoinositide 3-kinase (PI3K), cl	100.0
cd05175		366	PI3Kc_IA_alpha Phosphoinositide 3-kinase (PI3K), c	100.0
KOG0906		843	consensus Phosphatidylinositol 3-kinase VPS34, inv	100.0
PF02259		352	FAT: FAT domain; InterPro: IPR003151 The FAT domai	100.0
KOG0905		1639	consensus Phosphoinositide 3-kinase [Signal transd	99.98
KOG0904		1076	consensus Phosphatidylinositol 3-kinase catalytic	99.97
KOG0903		847	consensus Phosphatidylinositol 4-kinase, involved	99.93
KOG0902		1803	consensus Phosphatidylinositol 4-kinase [Signal tr	99.93
PTZ00303		1374	phosphatidylinositol kinase; Provisional	99.91
PF02260		33	FATC: FATC domain; InterPro: IPR003152 The FATC do	99.32
KOG0892		2806	consensus Protein kinase ATM/Tel1, involved in tel	98.84
TIGR02917		899	PEP_TPR_lipo putative PEP-CTERM system TPR-repeat	95.02
TIGR02917		899	PEP_TPR_lipo putative PEP-CTERM system TPR-repeat	92.88
PLN03081		697	pentatricopeptide (PPR) repeat-containing protein;	84.41
PRK10747		398	putative protoheme IX biogenesis protein; Provisio	84.4
PLN03218		1060	maturation of RBCL 1; Provisional	84.29
PF13575		370	DUF4135: Domain of unknown function (DUF4135)	84.15
PRK15174		656	Vi polysaccharide export protein VexE; Provisional	83.3

>KOG0892 consensus Protein kinase ATM/Tel1, involved in telomere length regulation and DNA repair [Signal transduction mechanisms; Chromatin structure and dynamics; Replication, recombination and repair; Cell cycle control, cell division, chromosome partitioning]	Back alignment and domain information

Probab=100.00  E-value=4.7e-167  Score=1606.83  Aligned_cols=1223  Identities=39%  Similarity=0.574  Sum_probs=980.0

Q ss_pred             cccCCChhHHHHHHHHHHhhcCCCcccHHHHHHHHHhhhCCCCCcEEEEecCCCccccccccCCCCCCCCCccceeccCc
Q 000578            5 VDWHSDHDIVHAVWTLVHMCCSDDASSIRAWVSDFISRVGIGDPHCVVFHLPRDSIYMHACRPINHGSGSATEFNFHLDA   84 (1412)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (1412)
                      .+|+.+++++..+|..+++-....+-+.....-+|+.+++..|+|.++|++|+..+++|+-.-..+.  .+.-+.-.+-.
T Consensus      1510 ~~~q~~~e~v~~~~~~~q~~~~~~~~~~~e~~~~~~~~v~~~~~~~L~~~~~~~~~~s~g~~i~~~~--~~~n~~~~~K~ 1587 (2806)
T KOG0892|consen 1510 WFWQKSPEIVDLVHYYPQTDPRLCDTSNYEPSKDFLWKVICQDDCSLLFKLPILLDSSIGIQIRMFF--EGSNIMELTKN 1587 (2806)
T ss_pred             hHHhcCccceechhhcccCChhhhhhcccCchhhhhhchhccccceEEEEcCcccccchhhhhhhcc--ccchhhhhhhh
Confidence            4799999999999999999999999999999999999999999999999999998877754432222  23333444556


Q ss_pred             cchHHHHHHHHHHHHHhhhcCcchhhchHHHHHHHHhccccccchhhchhHHHHHHHHHhhccCcchhHHhhhhhhhhhh
Q 000578           85 GISEELLIAVLKILKKYLMDDSVQIVDMTSQTLRGILSTEKGQRAVMSFDSYERSLLEVHSKGVNVELVETFLLDLERKF  164 (1412)
Q Consensus        85 ~~~~~~~~~il~~l~~~l~~~~~~~~~~a~~~L~~ilst~~g~~~~~~~~~~~~~~~e~~~~~~~~~l~~~~~~~~~~~~  164 (1412)
                      ++.++........+..+..+..+.+.....++....+++-.+......+..|.+.+++++                    
T Consensus      1588 ~i~~~dk~~~~~~~~~~~~~~~~~~~~il~~t~~es~s~w~s~~~ls~f~~c~~~~~~~~-------------------- 1647 (2806)
T KOG0892|consen 1588 LIFPLDKITLDSFLKTLVSEEGSFIIDILQQTNNESLSNWLSEFALKLFNMCGRSSTTHS-------------------- 1647 (2806)
T ss_pred             hccchhHHHHHHHHHHHhhccchhHHHHHhhhhccchhhHHHHHHHHHHHHHhccCCchh--------------------
Confidence            778888888888899999999999999999999999998888887777787777776632                    


Q ss_pred             hcCCCCCCCCcccccCCCcHHhhHHHHHHHhhccCCchhhhhhHHHHhccHhHHHHHhHHHHHHHhcCCCcchhHHHHHH
Q 000578          165 KANGISPEKSTVWETDGKTFETWICPLTYSLIGCCNDVVLRLCQDIVLLKSEVAELLLPSVVVNLAGSKNVDVDLQKLIS  244 (1412)
Q Consensus       165 ~~~~~~~~~~~~w~~~~~s~~~Wi~~l~~~Ll~~~~d~~Lr~~~~l~~~~~~~A~~LlP~~v~~i~~~~d~~~~~~~~ls  244 (1412)
                                  |.++......|++.++..+|-.+.+..   |..+....-.+-+.++|.+..        +        
T Consensus      1648 ------------~st~~~~~~t~i~~~i~~~l~~~s~~~---~~~~~~~~~yi~~~~~~sl~~--------n-------- 1696 (2806)
T KOG0892|consen 1648 ------------LSTYMANFSTSICQLIICLLLLESDFN---PGNNLKQKDYIFELILSSLLK--------N-------- 1696 (2806)
T ss_pred             ------------hccccccccHHHHHHHHHHHHhhcccc---HHHHHHHHHHHHHHHhhcccc--------c--------
Confidence                        445555678999999988875333322   444444444444444444321        0        


Q ss_pred             HHHHhhhhhcchhhhHHHHHHHHHHHHHhHhhHhhcccCCCCCcccccccccCCCCCCCccchhhhhhhhhhcccccccc
Q 000578          245 SQVQKYIFTESNKLIKSIQVFLNALNELRLCHVMERSSSVPPKRESSKYVKHSGSSAKPRSTSAKARDVVATSNATMTTS  324 (1412)
Q Consensus       245 ~~~~~~~~~~s~~~~~~iq~~l~~l~~LR~~~~~e~~~~~p~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~t~  324 (1412)
                                   .-....+-+|.+.++|.+   .+-.                                      .-+.
T Consensus      1697 -------------~~~~~~m~~ni~~~~~~~---~~~~--------------------------------------~~n~ 1722 (2806)
T KOG0892|consen 1697 -------------SNSIFKMDMNILKYLRRQ---LGCH--------------------------------------AFNP 1722 (2806)
T ss_pred             -------------hhHHHHHHHHHHHHHHHh---hchh--------------------------------------hhcc
Confidence                         011233445666666654   1110                                      0123


Q ss_pred             cccccccccCHHHHHHHHHHcCchhhHhhhhhhhhhhhhccccCCCCCCCcCCCcccHHHHHHHHHhhcCCCcccccccc
Q 000578          325 WDKVYWLSVDYLRVAKSAVICGSYFTSVMYVEHWCEEHYKSLTLGSPDFSHLETLPRHIEILVSAVTQINEPDSLYGIIQ  404 (1412)
Q Consensus       325 ~d~~~wL~Id~l~lA~AA~~C~ay~tALly~E~~~~~~~~~~~~~~~~~s~~~~~~~~~e~L~~Iy~~IdePD~~yGi~~  404 (1412)
                      |...+|+++++...+-++.+|.+|-..++|.=+.-.+          ..+........+++|.+||+.|++||++||+..
T Consensus      1723 ~~~~~~~~~~~~~~~~~~~~~~~~e~s~~~~t~~~~k----------~k~~e~~~~~lqDil~~~y~~I~~pD~lyG~~~ 1792 (2806)
T KOG0892|consen 1723 FEIYYWLPIVYSVAASTAYDCLLFEYSLLSLTIHSPK----------NKRDELDITLLQDILKKAYESINCPDALYGIKR 1792 (2806)
T ss_pred             hhhhccccHHHHHHHHHHHHHHHHHHHHHHHhhcCcc----------cchhHHHHHHHHHHHHHHHhhCCCcchhcccCC
Confidence            4456688888888888888888887777766542111          111122223456677777999999999999998


Q ss_pred             ccchh-hHHHHHHhhCCHHHHHHHHHHHhhcccccccCCCCCCCCCCCCCCcCCCCCcchhhhhccchhhHHHHHHHhhc
Q 000578          405 SHKLS-SQIVTLEHEGNWSKALEYYELQVRSDVMLQMDGNSGALSPHGLPSVHLSPSTSENEMMQRKPYKGLMRSLQQVG  483 (1412)
Q Consensus       405 ~~~l~-~~i~~yE~eg~W~kAL~~Yd~~l~~~~~~~~~~~s~~~~~~~~p~~~~~~~~~~~~~~~~~~~~Gl~r~L~~lG  483 (1412)
                      ...++ .++..+|||++|.+||..||..-.                  .|+     +  +       ...|.+++|++.|
T Consensus      1793 ~~~~~~~~l~~~~he~~w~~aL~~~d~~~~------------------~~s-----s--~-------~~~~~~~sLq~~g 1840 (2806)
T KOG0892|consen 1793 PTSLKNLILITAEHEKNWPRALSYYDLADM------------------YPS-----S--E-------DEAGFINSLQNAG 1840 (2806)
T ss_pred             cccccccccchhhhhhhHHHHHHhhcchhh------------------ccc-----h--H-------hHhHHHHHHHHhc
Confidence            88777 789999999999999999998753                  133     1  1       2489999999999


Q ss_pred             hhhHHHHhhhccccccCCCCCCccchHHHHHHHHhcCCCCCCccccCCCCCCCCCcccchhhhhHHHHHHHHhcCChHHH
Q 000578          484 CMHVLDMYCKGLTSWKGQFQHDPEFTKLQYEAAWRTGNWDFSLPYLGANFPSGQNIKSGHFHENLHSCLTALREGDSEEF  563 (1412)
Q Consensus       484 ~~~~L~~~~~gl~~~~~~~~~~~~~~~~~~eaAWrLg~WD~~~~~~~~~~~~~~~~~~~~f~~~l~~aL~Al~~~d~~~f  563 (1412)
                      +.|++.+|++|++...  ..++++..+..|++|||+|+||...+++-+    .....+.-||+.+|.+|+|+++++++++
T Consensus      1841 ~~~I~~~y~~Gl~~~~--~~~~~~~~e~~Ye~awr~g~Wd~~t~~~~~----~~~~~~~~y~e~~f~~l~al~ere~e~~ 1914 (2806)
T KOG0892|consen 1841 FFHILEFYIDGLKSND--KIDEPSNEELVYEAAWRLGKWDILTLSLVD----QNKTKGDYYHESLFEALRALHEREIEGS 1914 (2806)
T ss_pred             chhHHHHHhcChhhhh--hhhhhhhhhhhHHHHHhcCCcccCCcchhh----hhhhhchhHHHHHHHHHHHHHHHHHhhh
Confidence            9999999999999876  577889999999999999999986654311    1345667899999999999999999999


Q ss_pred             HHHHHHHHHHHHHHhhhhhhhhHHHHHHHHHHHHHHhHHHHHHhhhhhcc-CCccccccccccccCCCCCcchhhhhHHH
Q 000578          564 YRKLKHSKQELVLSVACASEESTEYIYSAIVKLQILCHLGVAWDIRWKSS-GESINIYPEKQKIVSEPVIPTVGQLSWLN  642 (1412)
Q Consensus       564 ~~~i~~aR~~l~~~Ls~~s~ES~~~~Y~~lvrLq~L~ELE~i~el~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  642 (1412)
                      ..+|+.+|...+..++..+.||....|+++.+||.+.+||.++++.+.+. +...-....+.....++..+..+.++.+.
T Consensus      1915 yl~le~a~~~~v~~i~~~see~~~~~y~~l~~L~~l~~l~~i~~l~~~~~~~~~~~~~~~k~~t~~q~~~~~~~~~~~~~ 1994 (2806)
T KOG0892|consen 1915 YLHLEDARNKKVLLINPNSEESSLSFYATLYDLQFLVTLEPIRCLQSTADKHQSNTDILQKWKTNLQLSSQLMECLSLLI 1994 (2806)
T ss_pred             HHHHHHHHHHHHHHhcccchHHHHHHHHHHHHHHHHhhhhhhHhhhhhhcchhhhhHHHHHHHHHHhhccchHHHHHHHH
Confidence            99999999999999999999999999999999999999999999877432 11000111111111122223444566666


Q ss_pred             HHHHHHHHhhhhhhhhhhhhHHHHHHHHHhhcCchHHHHHHHHHHHHHHhcCChhHHHHHHHHHHhhcCCCCCCCCchhh
Q 000578          643 TEWSSILKRTQLHMNLLEPFMAFRRVLLQILSCKDFTMQHLLESASTLRKGFRLSQAAAALHELKFLYTGPGDQCSTVYW  722 (1412)
Q Consensus       643 ~~W~~rl~~~~~~~~~~EpiL~~R~~vl~il~~~~~~~~~wl~~A~laRkag~~~~A~~aL~~l~~l~~~~~~q~~~~~~  722 (1412)
                      ..|+..+...+.+..+-++.++.+..++...++....+..-+..+.+.++-.+  .+.+...+.+.++            
T Consensus      1995 ~d~n~l~s~~~l~~~l~~~~~~~~~~~l~~~g~e~~~la~~~~~~~~~~~~~r--~~~~i~~~~~~~~------------ 2060 (2806)
T KOG0892|consen 1995 EDRNVLLSLLQLHKQLSESQLADLASLLKYYGLELCKLAESFLIADLLQNIAR--AFPVIMLSIKLLC------------ 2060 (2806)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhHHHHHHHHHhchhhHHhHHH--hhHHHHHHHHHHh------------
Confidence            77777776666666777777777777777767666666555555555555444  2333344433332            


Q ss_pred             hhhHHHHHHHHHCCChHHHHHHHHHH--------------HhhccCCCchhHHHHHHhHhHhhhhcCChHHHHHhhhhhh
Q 000578          723 LGRLEEAKLLRAQGQHEMAINLAKYI--------------SENYESNEEAPDVYRLVGKWLAESRSSNSRIILENYLKPA  788 (1412)
Q Consensus       723 ~a~iE~AklLWaqGe~~~AI~~Lq~l--------------~~~~~~~~~~a~ll~llg~Wlaetr~e~p~~I~~~Yl~~a  788 (1412)
                        .++.|+..|+++....+-.+|-..              .++........+.++.+|+|++|+++|+|..|+++|+++|
T Consensus      2061 --~~s~aq~~~k~~~~~~~e~iL~~~~~kne~~~~~s~~~~~~~~lk~~~~~~~a~~g~Wlaetk~ens~~i~e~yl~~a 2138 (2806)
T KOG0892|consen 2061 --KFSLAQENLKHDIDKLSEAILWQRDEKNEAIISLSESLAKNNSLKEFPSDIYAVLGKWLAETKSENSALISEKYLEKA 2138 (2806)
T ss_pred             --hhhhhhhhccchhhhhHHHHHHHHHhhhhHHHHHHhhhhhcchhhhhHHHHHHHHHHHHHHhhccchhhhHHHHHHHH
Confidence              233444444444333332222111              1222222345788999999999999999999999999999


Q ss_pred             cccccccccch-hhHHHHhhhhhhhHHHhHHHHHhhHHHHhchHHHHHHHHHHHhhHHHHHHHHHHHhhcccccchhhhH
Q 000578          789 VSFSEDQRTTD-KKSIERQCQTHFHLAHYADALFKSYEERLASNEWQAAMRLRKHKTIELEALIKRLKSSTKGEKTDYSI  867 (1412)
Q Consensus       789 ~~l~~~~~~~~-~~~~~~~~~~~~~la~f~D~~~~~~~~~~~~~e~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~y~~  867 (1412)
                      +..++.+.... +........+++++|+|.|.+|+.+++|+++.+|+.++++++...++++.+.+.-..    .++   .
T Consensus      2139 ~~~ae~~d~e~~~~~~~~~s~a~~~~akysd~~~~~~~~~~~sse~et~~~l~k~~~~~~~~~~er~~q----~~~---~ 2211 (2806)
T KOG0892|consen 2139 VSLAEHYDNESCKALIYCQSFAQFCLAKYSDPDYQEDEERRSSSEFETLKDLQKLERSTVEASNEREEQ----MRK---N 2211 (2806)
T ss_pred             HHHhhhcchhHHHHHHhHHHHHHHHHHhccCchhhhHHHHHhHHHHhhHHHHHHHHHhhhhhhHHHHHH----HHH---H
Confidence            98887663222 222344578999999999999999999999999999999999999998866544321    111   2


Q ss_pred             HHHHHHHHhhccHHHHHHhHhhHHHHHHHHHHHHHHHHhcCCCcchHHHHHHHHhhccCcchHHHHHHHHHhHHH-----
Q 000578          868 KIQELQKQLAMDREEAQKLLDDRDNFLGLALEGYKRCLVIGDKYDVRVVFRLVSLWFSLSSRQNVIKNMVDTIDE-----  942 (1412)
Q Consensus       868 ~~~~~~~~~~~d~~e~~~l~~~~~~fl~~al~~y~~~l~~~~~~~~~~~~R~~sLW~~~~~~~~~~~~~~~~~~~-----  942 (1412)
                      +..+.++++.+|+++++++..+|++||++|++||++|+..|++||.+.++|+|+|||+|+..+++|+.|.+.+.+     
T Consensus      2212 ~~~~~~rq~~lDe~~l~~l~~~r~~fL~~Alt~Yl~cl~~~~~~D~~~i~R~cslWfsns~~~evn~~mk~~i~~ipsyK 2291 (2806)
T KOG0892|consen 2212 HHVRVQRQLILDEEELLALSEDRSKFLTLALTNYLNCLSESDEYDVDLIFRCCSLWFSNSHLKEVNNSLKHEIQTVPSYK 2291 (2806)
T ss_pred             HHHHHHHHHhccHHHHHHHHHHHHHHHHHHHHhHHHHHhhcccccHHHHHHHhhhhccccchHHHHHHHHHHhccCCcch
Confidence            345678999999999999999999999999999999999999999999999999999999999998888765432     


Q ss_pred             ------------------------------------------HHhhhccCc-cccccccccccccchhHHHHHHHHHHHH
Q 000578          943 ------------------------------------------LLALANGDR-IKDKQRSRNSFVVDMDKKLAAENLLEEL  979 (1412)
Q Consensus       943 ------------------------------------------l~al~~~~~-~~~~~~~~~~~~~~~~~~~aa~~i~~~~  979 (1412)
                                                                |+++.++.+ .+..+++|.+  ++++|+.+|+.++...
T Consensus      2292 Fip~~yQlAaRl~~~~~~~fq~~L~~Li~r~~~dhPyhtly~L~~L~~~~rd~e~~n~sr~s--l~~~rki~a~l~~~~v 2369 (2806)
T KOG0892|consen 2292 FIPLVYQLAARLGNSENNSFQKSLTSLIYRVGRDHPYHTLYQLLSLVNAVRDNEDENRSRGS--IDRDRKIAAELDLCDV 2369 (2806)
T ss_pred             hHHHHHHHHHHhccccCchHHHHHHHHHHHHhccCchHHHHHHHHHHhcCcChhhhhhcccc--cchhHHHHHHHhhhHh
Confidence                                                      455666655 3344566664  6789999999999999


Q ss_pred             hhhhHHHHHHHHHHHHHHHHHHhhhccccccccc-ccchhhhh--hhhcccccccccccccCCCCccccCCCCccccccC
Q 000578          980 SSYHGAIIRQMKQMVDVYIKLAELETRREDTNKR-IQLPREIR--CLRQLELVPVVTATVPIDCTCQYNEGSFPYFKGLA 1056 (1412)
Q Consensus       980 ~~~~~~~~~~~~~~~~~~~~la~~~~~~~~~~~~-~~l~~~~~--~l~~l~~~p~~t~~lp~~~~~~y~~~~~~~i~~~~ 1056 (1412)
                      ....+.++++++.+|++||.||++++...++.++ +.+|....  ...+++.+|+||+++++++++.|  +++|+|.+|.
T Consensus      2370 ~~~~~~~v~~v~~lc~~yI~lAnl~~~q~~t~~k~v~~p~~~~~~K~~nl~~v~~pT~ev~v~~s~~~--~~~p~i~s~~ 2447 (2806)
T KOG0892|consen 2370 NQGAGNMVRQLECLCEAYISLANLKTSQNDTTSKLVRLPGYQWFLKQLNLEGVPPPTMNVKVNDSGDY--GNIPTVVSFD 2447 (2806)
T ss_pred             hccchhHHHHHHHHHHHHHHHhcCcccccchhhhhhcCccccHHHhhhhccCCCCCCCCccccCCccc--CCCceEEecc
Confidence            9999999999999999999999988777776666 66666544  44567888999999999988755  5589999999


Q ss_pred             CeEEEecCCCcceEEEEEeCCCceEeeeeecCccchhhHHHHHHHHHHHHHHHhcCcccccccceeecceEEEcCCCCcc
Q 000578         1057 ESVMVMNGINAPKVVECFGSDGHKYRQLAKSGNDDLRQDAVMEQFFGLVNTFLRNHRDTWKRRLGVRTYKVVPFTPSAGI 1136 (1412)
Q Consensus      1057 ~~v~v~~s~~~Pk~i~~~gsdG~~y~~L~K~G~dDLRqD~r~~Qlf~liN~lL~~~~etr~r~L~i~tY~ViPLs~~~GL 1136 (1412)
                      ++|.+++|++.||+|+|+||||++|++|+|+|+||||||++|+|+|+++|++|.++++|++|+|.||||+||||+|++|+
T Consensus      2448 ~~v~~~~GinaPkiI~c~gSDG~~~kqLVK~gnDDLRQDAVMeQvF~~vN~lL~~~~et~krkL~irTYKVvPls~~sGv 2527 (2806)
T KOG0892|consen 2448 DTVTFAGGINAPKVITCVGSDGKTYKQLVKGGNDDLRQDAVMEQVFGQVNTFLQNDRETRKRKLSIRTYKVIPLSPKAGV 2527 (2806)
T ss_pred             cceeeecCccCCeEEEEEccCchhHHHHHhcccchHHHHHHHHHHHHHHHHHhhccHHHHhcccceeEEeeeecCcccce
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ceecCCCCchHHHhhhhccCCCCCCCCCCCcchhHHHHhhhcchH-----hHHHHHHHHHhhhhhhHHHHHHHHcCCchH
Q 000578         1137 LEWVDGTVPLGDYLIGSTRNGGAHGRYGIGDWSFLKCREHMSNVK-----DKRIAFQEVCENFRPVLHYFFLERFLQPAY 1211 (1412)
Q Consensus      1137 IE~v~~t~sL~~il~~~~~~~~~~~r~~~~~~~~~~~r~~~~~~~-----~k~~~f~~i~~~~~pvl~~~f~~~f~~p~~ 1211 (1412)
                      ||||.||+||++||....  +|+|+||+|.+|++.+||+.|.+.+     +|+++|.+||.+++||||+||+|+||+|.+
T Consensus      2528 lEwv~~tiplgeyLv~~~--~gah~ry~p~d~s~~~crk~m~~~q~k~~E~r~k~y~~vc~n~~PvfryFflEkF~dP~~ 2605 (2806)
T KOG0892|consen 2528 LEWVTNTIPLGEYLVVES--GGAHKRYRPNDWSLSKCRKLMSEVQKKSLETRLKAYDKVCRNIRPVFRYFFLEKFPDPAD 2605 (2806)
T ss_pred             eecccCCeehhhhhcccC--CccccccCCCCCChHHHHHHHHHHhcccHHHHHHHHHHHHhhchHHHHHHHHHhcCCHHH
Confidence            999999999999997543  8999999999999999999998776     899999999999999999999999999999


Q ss_pred             HHHHHHHHHHhhhhhhHHHhhhccCCCCCCeEEEecCCCcEEEEecchhhccccCCCCCCCCcccccccccccccccccc
Q 000578         1212 WFEKRLAYTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFEQGLMLKTPERVPFRLTRDIIDGMGVTGVE 1291 (1412)
Q Consensus      1212 w~~~R~~ft~S~A~~S~vgyilGLGDRH~~NILld~~tG~vvhIDfg~~f~~g~~l~~pE~VPFRLTrniv~~mG~~g~e 1291 (1412)
                      ||++|++||||+|+.|||||||||||||.+|||||..||||||||||++||||+.+|+||+||||||||||||||+||||
T Consensus      2606 WFekrlaYTrsvA~sS~VGyILGLGDRH~qNILid~~taEviHIDlGiAFEQGkilptPE~VPFRLTRDiVdgmGItGve 2685 (2806)
T KOG0892|consen 2606 WFEKRLAYTRSVAASSMVGYILGLGDRHGQNILIDQQTAEVIHIDLGIAFEQGKILPTPETVPFRLTRDIVDGMGITGVE 2685 (2806)
T ss_pred             HHHHHHHHHHhHHHHHHHHHHhcccchhhhheeecccccceEEEeeeeehhcCCcCCCCCcccceeehhhccccCccCch
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             chhHHHHHHHHHHHhcChHHHHHHHHHHccCCCcccccChhHHHhhhhcccccccCCCCCCcccccc-chhHHHHHHHHH
Q 000578         1292 GVFRRCCEKTLSVMRTNKEALLTIVEVFIHDPLYKWALSPLKALQRQKEMDDDLETGLEGPEDEYEG-NKDAERALIRVK 1370 (1412)
Q Consensus      1292 G~Fr~~~~~t~~~LR~~~~~l~~iL~~f~~DpL~~W~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-n~~a~~~l~rv~ 1370 (1412)
                      |+||+|||.||.+||++++.+++|||+|+||||++|.++|.|+..+|++ ++....+.+........ +..|.|++.|++
T Consensus      2686 GvFrRccE~t~~vlR~~~~~lltileVl~yDPLf~W~msplK~~~~q~~-e~~e~~n~~~~~~~~~~nd~~a~r~l~r~q 2764 (2806)
T KOG0892|consen 2686 GVFRRCCEFTLEVLRREKESLLTILEVLLYDPLFSWLMSPLKALKKQKE-EDEENFNLSGNITEDASNDRNAVRALMRAQ 2764 (2806)
T ss_pred             HHHHHHHHHHHHHHHhhhHHHHHHHHHHHhcchHHHhhcHHHHHHHHHh-hcchhcccccchhhhhccchHHHHHHHHHH
Confidence            9999999999999999999999999999999999999999999999986 33333333332222223 578999999999


Q ss_pred             hhccCCCCCCccCHHHHHHHHHHHccChhhhhhhccccccCC
Q 000578         1371 QKLDGYEGGEMRSVHGQVQQLIQDAIDPERFCLMFPGWGAWL 1412 (1412)
Q Consensus      1371 ~kL~g~~~~~~lsv~~qV~~LI~~Atd~~NLa~m~~gW~Pwl 1412 (1412)
                      +||.|.+.|..+||++||++||||||||+|||+|||||.||+
T Consensus      2765 ~kl~g~e~g~~~sVe~qv~~LIqqA~dpsnLs~~fpGW~a~~ 2806 (2806)
T KOG0892|consen 2765 RKLDGVEQGTMLSVEAQVQELIQQATDPSNLSLMFPGWSAFQ 2806 (2806)
T ss_pred             HHhhhhhccccccHHHHHHHHHHHhcCchhhhhhcCCCcCcC
Confidence            999999999999999999999999999999999999999996

>KOG0890 consensus Protein kinase of the PI-3 kinase family involved in mitotic growth, DNA repair and meiotic recombination [Signal transduction mechanisms; Chromatin structure and dynamics; Replication, recombination and repair; Cell cycle control, cell division, chromosome partitioning]	Back alignment and domain information

>KOG0891 consensus DNA-dependent protein kinase [Replication, recombination and repair]	Back alignment and domain information

>COG5032 TEL1 Phosphatidylinositol kinase and protein kinases of the PI-3 kinase family [Signal transduction mechanisms / Cell division and chromosome partitioning / Chromatin structure and dynamics / DNA replication, recombination, and repair / Intracellular trafficking and secretion]	Back alignment and domain information

>cd05171 PIKKc_ATM Ataxia telangiectasia mutated (ATM), catalytic domain; The ATM catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases	Back alignment and domain information

>cd05170 PIKKc_SMG1 Suppressor of morphogenetic effect on genitalia-1 (SMG-1), catalytic domain; The SMG-1 catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases	Back alignment and domain information

>cd05163 TRRAP TRansformation/tRanscription domain-Associated Protein (TRRAP), pseudokinase domain; The TRRAP catalytic domain is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases	Back alignment and domain information

>cd05169 PIKKc_TOR TOR (Target of rapamycin), catalytic domain; The TOR catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases	Back alignment and domain information

>cd05172 PIKKc_DNA-PK DNA-dependent protein kinase (DNA-PK), catalytic domain; The DNA-PK catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases	Back alignment and domain information

>cd00892 PIKKc_ATR ATR (Ataxia telangiectasia and Rad3-related), catalytic domain; The ATR catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases	Back alignment and domain information

>cd05164 PIKKc Phosphoinositide 3-kinase-related protein kinase (PIKK) subfamily, catalytic domain; The PIKK catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases	Back alignment and domain information

>cd00142 PI3Kc_like Phosphoinositide 3-kinase (PI3K)-like family, catalytic domain; The PI3K-like catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases	Back alignment and domain information

>cd00891 PI3Kc Phosphoinositide 3-kinase (PI3K), catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases	Back alignment and domain information

>cd00896 PI3Kc_III Phosphoinositide 3-kinase (PI3K), class III, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases	Back alignment and domain information

>KOG0889 consensus Histone acetyltransferase SAGA, TRRAP/TRA1 component, PI-3 kinase superfamily [Signal transduction mechanisms; Chromatin structure and dynamics; Replication, recombination and repair; Cell cycle control, cell division, chromosome partitioning]	Back alignment and domain information

>cd05166 PI3Kc_II Phosphoinositide 3-kinase (PI3K), class II, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases	Back alignment and domain information

>cd05177 PI3Kc_C2_gamma Phosphoinositide 3-kinase (PI3K), class II, gamma isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases	Back alignment and domain information

>cd05165 PI3Kc_I Phosphoinositide 3-kinase (PI3K), class I, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases	Back alignment and domain information

>cd05168 PI4Kc_III_beta Phosphoinositide 4-kinase (PI4K), Type III, beta isoform, catalytic domain; The PI4K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases	Back alignment and domain information

>smart00146 PI3Kc Phosphoinositide 3-kinase, catalytic domain	Back alignment and domain information

>cd00894 PI3Kc_IB_gamma Phosphoinositide 3-kinase (PI3K), class IB, gamma isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases	Back alignment and domain information

>cd05174 PI3Kc_IA_delta Phosphoinositide 3-kinase (PI3K), class IA, delta isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases	Back alignment and domain information

>cd05176 PI3Kc_C2_alpha Phosphoinositide 3-kinase (PI3K), class II, alpha isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases	Back alignment and domain information

>cd00893 PI4Kc_III Phosphoinositide 4-kinase (PI4K), Type III, catalytic domain; The PI4K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases	Back alignment and domain information

>cd05173 PI3Kc_IA_beta Phosphoinositide 3-kinase (PI3K), class IA, beta isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases	Back alignment and domain information

>PF00454 PI3_PI4_kinase: Phosphatidylinositol 3- and 4-kinase; InterPro: IPR000403 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases	Back alignment and domain information

>cd05167 PI4Kc_III_alpha Phosphoinositide 4-kinase (PI4K), Type III, alpha isoform, catalytic domain; The PI4K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases	Back alignment and domain information

>cd00895 PI3Kc_C2_beta Phosphoinositide 3-kinase (PI3K), class II, beta isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases	Back alignment and domain information

>cd05175 PI3Kc_IA_alpha Phosphoinositide 3-kinase (PI3K), class IA, alpha isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases	Back alignment and domain information

>KOG0906 consensus Phosphatidylinositol 3-kinase VPS34, involved in signal transduction [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]	Back alignment and domain information

>PF02259 FAT: FAT domain; InterPro: IPR003151 The FAT domain is a domain present in the PIK-related kinases	Back alignment and domain information

>KOG0905 consensus Phosphoinositide 3-kinase [Signal transduction mechanisms]	Back alignment and domain information

>KOG0904 consensus Phosphatidylinositol 3-kinase catalytic subunit (p110) [Signal transduction mechanisms]	Back alignment and domain information

>KOG0903 consensus Phosphatidylinositol 4-kinase, involved in intracellular trafficking and secretion [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]	Back alignment and domain information

>KOG0902 consensus Phosphatidylinositol 4-kinase [Signal transduction mechanisms]	Back alignment and domain information

>PTZ00303 phosphatidylinositol kinase; Provisional	Back alignment and domain information

>PF02260 FATC: FATC domain; InterPro: IPR003152 The FATC domain is found at the C-terminal end of the PIK-related kinases	Back alignment and domain information

>KOG0892 consensus Protein kinase ATM/Tel1, involved in telomere length regulation and DNA repair [Signal transduction mechanisms; Chromatin structure and dynamics; Replication, recombination and repair; Cell cycle control, cell division, chromosome partitioning]	Back alignment and domain information

>TIGR02917 PEP_TPR_lipo putative PEP-CTERM system TPR-repeat lipoprotein	Back alignment and domain information

>TIGR02917 PEP_TPR_lipo putative PEP-CTERM system TPR-repeat lipoprotein	Back alignment and domain information

>PLN03081 pentatricopeptide (PPR) repeat-containing protein; Provisional	Back alignment and domain information

>PRK10747 putative protoheme IX biogenesis protein; Provisional	Back alignment and domain information

>PLN03218 maturation of RBCL 1; Provisional	Back alignment and domain information

>PF13575 DUF4135: Domain of unknown function (DUF4135)	Back alignment and domain information

>PRK15174 Vi polysaccharide export protein VexE; Provisional	Back alignment and domain information

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Alignment Graph	Length	Definition	E-value
Query		1412
2y3a_A		1092	Crystal Structure Of P110beta In Complex With Icsh2		8e-11
2x6f_A		696	The Crystal Structure Of The Drosophila Class Iii P		6e-09
3ls8_A		614	Crystal Structure Of Human Pik3c3 In Complex With 3		2e-08
3ihy_A		600	Human Pik3c3 Crystal Structure Length = 600		2e-08
1e8x_A		961	Structural Insights Into Phoshoinositide 3-Kinase E		5e-07
1e7u_A		961	Structure Determinants Of Phosphoinositide 3-Kinase		5e-07
3l54_A		966	Structure Of Pi3k Gamma With Inhibitor Length = 966		4e-06
3dbs_A		960	Structure Of Pi3k Gamma In Complex With Gdc0941 Len		4e-06
3cst_A		966	Crystal Structure Of Pi3k P110gamma Catalytical Dom		4e-06
1he8_A		965	Ras G12v-Pi 3-Kinase Gamma Complex Length = 965		4e-06
4dk5_A		959	Crystal Structure Of Human Pi3k-Gamma In Complex Wi		4e-06
3nzs_A		954	Structure-Based Optimization Of Pyrazolo -Pyrimidin		4e-06
3ene_A		959	Complex Of Pi3k Gamma With An Inhibitor Length = 95		4e-06
1e8y_A		966	Structure Determinants Of Phosphoinositide 3-Kinase		4e-06
3qaq_A		960	Crystal Structure Of Pi3k-Gamma In Complex With Tri		4e-06
3apc_A		966	Crystal Structure Of Human Pi3k-Gamma In Complex Wi		5e-06
4anv_A		980	Complexes Of Pi3kgamma With Isoform Selective Inhib		5e-06
4anu_A		980	Complexes Of Pi3kgamma With Isoform Selective Inhib		5e-06
4anx_A		980	Complexes Of Pi3kgamma With Isoform Selective Inhib		1e-05
4ajw_A		934	Discovery And Optimization Of New Benzimidazole- An		2e-05
2wxf_A		940	The Crystal Structure Of The Murine Class Ia Pi 3-K		2e-05
3zim_A		940	Discovery Of A Potent And Isoform-selective Targete		9e-05
3hhm_A		1091	Crystal Structure Of P110alpha H1047r Mutant In Com		1e-04
2rd0_A		1096	Structure Of A Human P110alpha/p85alpha Complex Len		1e-04
3hiz_A		1096	Crystal Structure Of P110alpha H1047r Mutant In Com		1e-04
4a55_A		1096	Crystal Structure Of P110alpha In Complex With Ish2		1e-04

>pdb|2Y3A|A Chain A, Crystal Structure Of P110beta In Complex With Icsh2 Of P85beta And The Drug Gdc-0941 Length = 1092